Atrial Fibrillation
Catheter Ablation
Ventricular Fibrillation
Anti-Arrhythmia Agents
Pulmonary Veins
Electric Countershock
Warfarin
Atrial Flutter
Electrocardiography
Electrophysiologic Techniques, Cardiac
Amiodarone
Cardiac Pacing, Artificial
Heart Conduction System
Treatment Outcome
Thromboembolism
Stroke
Refractory Period, Electrophysiological
Atrial Premature Complexes
Follow-Up Studies
Propafenone
Electrocardiography, Ambulatory
Body Surface Potential Mapping
beta-Alanine
Flecainide
Risk Factors
Pacemaker, Artificial
Prospective Studies
Atrioventricular Node
Sick Sinus Syndrome
International Normalized Ratio
Embolism
Echocardiography, Transesophageal
Wolff-Parkinson-White Syndrome
Arrhythmias, Cardiac
Bepridil
Tachycardia
Tachycardia, Ectopic Atrial
Digoxin
Chronic Disease
Dogs
Risk Assessment
Arrhythmia, Sinus
Tachycardia, Supraventricular
Incidence
Echocardiography
Retrospective Studies
Atrial Septum
Heart Failure
Sinoatrial Node
Predictive Value of Tests
Postoperative Complications
Heart Valve Diseases
Bradycardia
Defibrillators, Implantable
Heart Diseases
Aspirin
Pericardium
Atrial Remodeling
Cerebrovascular Disorders
Electrophysiology
Heart Block
Tachycardia, Ventricular
Disopyramide
Models, Cardiovascular
Chi-Square Distribution
Adrenergic beta-Antagonists
Comorbidity
Action Potentials
Multivariate Analysis
Aprindine
Mitral Valve Stenosis
Coronary Artery Bypass
Prognosis
Autonomic Denervation
Cohort Studies
Vitamin K
Age Factors
Cardiac Complexes, Premature
Rheumatic Heart Disease
Pulmonary Veno-Occlusive Disease
Stroke Volume
Coronary Sinus
Heart Arrest
Proportional Hazards Models
Esophageal Fistula
Ventricular Dysfunction, Left
Heart Ventricles
Signal Processing, Computer-Assisted
Kaplan-Meier Estimate
Prevalence
Platelet Aggregation Inhibitors
Logistic Models
Epicardial Mapping
Vena Cava, Superior
Cardiac Catheters
Pericarditis
Randomized Controlled Trials as Topic
Atrioventricular Block
Quinidine
Digitalis Glycosides
Feasibility Studies
Echocardiography, Doppler
Ablation Techniques
Brain Ischemia
Cardiac Catheterization
Double-Blind Method
Bundle of His
Surgery, Computer-Assisted
Cardiac Electrophysiology
Registries
Thyrotoxicosis
Case-Control Studies
Autonomic Nervous System
Thiophenes
Defibrillators
Luria-Nebraska Neuropsychological Battery
Intracranial Hemorrhages
Electrophysiological Phenomena
Death, Sudden, Cardiac
Myocardial Infarction
Vagus Nerve
Mitral Valve Insufficiency
Heart Valve Prosthesis Implantation
Anisoles
Electrodes
Ventricular Function, Left
Antithrombins
Cardiopulmonary Resuscitation
Intracranial Embolism
Premedication
Heart Valves
Voltage-Sensitive Dye Imaging
Endpoint Determination
Electric Injuries
Disease Models, Animal
Telemetry
Hypertension
Practice Guidelines as Topic
Fibrosis
Hemodynamics
Hyperthyroidism
Severity of Illness Index
Denmark
Thoracic Surgical Procedures
Ischemic Attack, Transient
Biological Markers
Vagus Nerve Stimulation
Cardiovascular Agents
Intracranial Embolism and Thrombosis
Myocardium
Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. (1/5583)
BACKGROUND: We correlated the electrophysiologic (EP) effects of adenosine with tachycardia mechanisms in patients with supraventricular tachycardias (SVT). METHODS AND RESULTS: Adenosine was administered to 229 patients with SVTs during EP study: atrioventricular (AV) reentry (AVRT; n=59), typical atrioventricular node reentry (AVNRT; n=82), atypical AVNRT (n=13), permanent junctional reciprocating tachycardia (PJRT; n=12), atrial tachycardia (AT; n=53), and inappropriate sinus tachycardia (IST; n=10). There was no difference in incidence of tachycardia termination at the AV node in AVRT (85%) versus AVNRT (86%) after adenosine, but patients with AVRT showed increases in the ventriculoatrial (VA) intervals (13%) compared with typical AVNRT (0%), P<0.005. Changes in atrial, AV, or VA intervals after adenosine did not predict the mode of termination of long R-P tachycardias. For patients with AT, there was no correlation with location of the atrial focus and adenosine response. AV block after adenosine was only observed in AT patients (27%) or IST (30%). Patients with IST showed atrial cycle length increases after adenosine (P<0.05) with little change in activation sequence. The incidence of atrial fibrillation after adenosine was higher for those with AVRT (15%) compared with typical AVNRT (0%) P<0.001, or atypical AVNRT (0%) but similar to those with AT (11%) and PJRT (17%). CONCLUSIONS: The EP response to adenosine proved of limited value to identify the location of AT or SVT mechanisms. Features favoring AT were the presence of AV block or marked shortening of atrial cycle length before tachycardia suppression. Atrial fibrillation was more common after adenosine in patients with AVRT, PJRT, or AT. Patients with IST showed increases in cycle length with little change in atrial activation sequence after adenosine. (+info)Regional differences in the recovery course of tachycardia-induced changes of atrial electrophysiological properties. (2/5583)
BACKGROUND: Regional differences in recovery of tachycardia-induced changes of atrial electrophysiological properties have not been well studied. METHODS AND RESULTS: In the control group (5 dogs), atrial effective refractory period (AERP) and inducibility of atrial fibrillation (AF) were assessed before and every 4 hours for 48 hours after complete atrioventricular junction (AVJ) ablation with 8-week VVI pacing. In experimental group 1 (15 dogs), AERP and inducibility of AF were assessed before and after complete AVJ ablation with 8-week rapid right atrial (RA) pacing (780 bpm) and VVI pacing. In experimental group 2 (7 dogs), AERP and inducibility of AF were assessed before and after 8-week rapid left atrial (LA) pacing and VVI pacing. AERP and inducibility and duration of AF were obtained from 7 epicardial sites. In the control group, atrial electrophysiological properties obtained immediately and during 48-hour measurements after pacing did not show any change. In the 2 experimental groups, recovery of atrial electrophysiological properties included a progressive recovery of AERP shortening, recovery of AERP maladaptation, and decrease of duration and episodes of reinduced AF. However, recovery of shortening and maladaptation of AERP and inducibility of AF was slower at the LA than at the RA and Bachmann's bundle. CONCLUSIONS: The LA had a slower recovery of tachycardia-induced changes of atrial electrophysiological properties, and this might play a critical role in initiation of AF. (+info)Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes. (3/5583)
OBJECTIVE: 5-HT4 receptors are present in human atrial cells and their stimulation has been implicated in the genesis of atrial arrhythmias including atrial fibrillation. An I(f)-like current has been recorded in human atrial myocytes, where it is modulated by beta-adrenergic stimulation. In the present study, we investigated the effect of serotonin (5-hydroxytryptamine, 5-HT) on I(f) electrophysiological properties, in order to get an insight into the possible contribution of I(f) to the arrhythmogenic action of 5-HT in human atria. METHODS: Human atrial myocytes were isolated by enzymatic digestion from samples of atrial appendage of patients undergoing coeffective cardiac surgery. Patch-clamped cells were superfused with a modified Tyrode's solution in order to amplify I(f) and reduce overlapping currents. RESULTS AND CONCLUSIONS: A time-dependent, cesium-sensitive increasing inward current, that we had previously described having the electrophysiological properties of the pacemaker current I(f), was elicited by negative steps (-60 to -130 mV) from a holding potential of -40 mV. Boltzmann fit of control activation curves gave a midpoint (V1/2) of -88.9 +/- 2.6 mV (n = 14). 5-HT (1 microM) consistently caused a positive shift of V1/2 of 11.0 +/- 2.0 mV (n = 8, p < 0.001) of the activation curve toward less negative potentials, thus increasing the amount of current activated by clamp steps near the physiological maximum diastolic potential of these cells. The effect was dose-dependent, the EC50 being 0.14 microM. Maximum current amplitude was not changed by 5-HT. 5-HT did not increase I(f) amplitude when the current was maximally activated by cAMP perfused into the cell. The selective 5-HT4 antagonists, DAU 6285 (10 microM) and GR 125487 (1 microM), completely prevented the effect of 5-HT on I(f). The shift of V1/2 caused by 1 microM 5-HT in the presence of DAU 6285 or GR 125487 was 0.3 +/- 1 mV (n = 6) and 1.0 +/- 0.6 mV (n = 5), respectively (p < 0.01 versus 5-HT alone). The effect of 5-HT4 receptor blockade was specific, since neither DAU 6285 nor GR 125487 prevented the effect of 1 microM isoprenaline on I(f). Thus, 5-HT4 stimulation increases I(f) in human atrial myocytes; this effect may contribute to the arrhythmogenic action of 5-HT in human atrium. (+info)Effects of cycloprotobuxine-A on atrial fibrillation. (4/5583)
AIM: To study the effects of cycloprotobuxine-A (Cyc-A) on atrial fibrillation. METHODS: Atrial fibrillations in vivo and in vitro were induced by arrhythmogenic drugs. Action potentials were measured by the standard microelectrode technique. RESULTS: Cyc-A, similar to or slightly stronger than amiodarone (Ami), decreased incidences of atrial fibrillation elicited by CaCl2-acetylcholine in mice and increased doses of aconitine, ouabain, or adrenaline to elicit atrial fibrillation in isolated guinea pig atria. Cyc-A 0.3-100 mumol.L-1 decreased the normal automaticity and 0.3-30 mumol.L-1 attenuated or almost abolished the isoprenaline-induced abnormal increase in automaticity in sinus nodal cells. In isolated left atria, Cyc-A 0.3-30 mumol.L-1 inhibited the abnormal rhythmic activity elicited by adrenaline, prolonged action potential duration (APD) and effective refractory period, and reduced excitability. At 3-30 mumol.L-1, Cyc-A also decreased the maximal velocity of depolarization (Vmax). Cyc-A antagonized the acetylcholine-induced shortening of APD. These electrophysiologic effects were similar to those of amiodarone, but Ami did not affect the Vmax. CONCLUSION: Cyc-A produces a protective effect against experimental atrial fibrillation via a prolongation of repolarization, a decease of automaticity, and an inhibition of excitability. (+info)Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation. (5/5583)
OBJECTIVE: To assess the effect of atrioventricular node ablation and implantation of a dual chamber, mode switching pacemaker on quality of life, exercise capacity, and left ventricular systolic function in patients with drug refractory paroxysmal atrial fibrillation. PATIENTS: 18 consecutive patients with drug refractory paroxysmal atrial fibrillation. METHODS: Quality of life was assessed before and after the procedure using the psychological general wellbeing index (PGWB), the McMaster health index (MHI), and a visual analogue scale for cardiac symptoms. Nine of the patients also underwent symptom limited exercise tests and echocardiography to assess left ventricular systolic function. RESULTS: The procedure allowed a reduction in antiarrhythmic drug treatment (p < 0.01). PGWB and symptom scores improved (p < 0.01) but the MHI score did not change. Left ventricular systolic function and exercise capacity were unchanged. CONCLUSIONS: Atrioventricular node ablation and implantation of a DDDR/MS pacemaker is effective treatment for refractory paroxysmal atrial fibrillation, producing improved quality of life while allowing a reduction in drug burden. The popularity of the treatment is justified, but further studies are needed to determine optimum timing of intervention. (+info)Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias. (6/5583)
OBJECTIVE: To assess the natural history of the atrial rhythm of patients with paroxysmal atrial arrhythmias undergoing atrioventricular node ablation and permanent pacemaker implantation. DESIGN AND SETTING: A retrospective cohort study of consecutive patients identified from the pacemaker database and electrophysiology records of a tertiary referral hospital. PATIENTS: 62 consecutive patients with paroxysmal atrial arrhythmias undergoing atrioventricular node ablation and permanent pacemaker implantation between 1988 and July 1996. MAIN OUTCOME MEASURES: (1) Atrial rhythm on final follow up ECG, classified as either ordered (sinus rhythm or atrial pacing) or disordered (atrial fibrillation, atrial flutter or atrial tachycardia). (2) Chronic atrial fibrillation, defined as a disordered rhythm on two consecutive ECGs (or throughout a 24 hour Holter recording) with no ordered rhythm subsequently documented. RESULTS: Survival analysis showed that 75% of patients progressed to chronic atrial fibrillation by 2584 days (86 months). On multiple logistic regression analysis a history of electrical cardioversion, increasing patient age, and VVI pacing were associated with the development of chronic atrial fibrillation. A history of electrical cardioversion and increasing patient age were associated with a disordered atrial rhythm on the final follow up ECG. CONCLUSIONS: Patients with paroxysmal atrial arrhythmias are at high risk of developing chronic atrial fibrillation. A history of direct current cardioversion. (+info)Differential effects of defibrillation on systemic and cardiac sympathetic activity. (7/5583)
OBJECTIVE: To assess the effect of defibrillation shocks on cardiac and circulating catecholamines. DESIGN: Prospective examination of myocardial catecholamine balance during dc shock by simultaneous determination of arterial and coronary sinus plasma concentrations. Internal countershocks (10-34 J) were applied in 30 patients after initiation of ventricular fibrillation for a routine implantable cardioverter defibrillator test. Another 10 patients were externally cardioverted (50-360 J) for atrial fibrillation. MAIN OUTCOME MEASURES: Transcardiac noradrenaline, adrenaline, and lactate gradients immediately after the shock. RESULTS: After internal shock, arterial noradrenaline increased from a mean (SD) of 263 (128) pg/ml at baseline to 370 (148) pg/ml (p = 0.001), while coronary sinus noradrenaline fell from 448 (292) to 363 (216) pg/ml (p = 0.01), reflecting a shift from cardiac net release to net uptake. After external shock delivery, there was a similar increase in arterial noradrenaline, from 260 (112) to 459 (200) pg/ml (p = 0.03), while coronary sinus noradrenaline remained unchanged. Systemic adrenaline increased 11-fold after external shock (p = 0.01), outlasting the threefold rise following internal shock (p = 0.001). In both groups, a negative transmyocardial adrenaline gradient at baseline decreased further, indicating enhanced myocardial uptake. Cardiac lactate production occurred after ventricular fibrillation and internal shock, but not after external cardioversion, so the neurohumoral changes resulted from the defibrillation process and not from alterations in oxidative metabolism. CONCLUSIONS: A dc shock induces marked systemic sympathoadrenal and sympathoneuronal activation, but attenuates cardiac sympathetic activity. This might promote the transient myocardial depression observed after electrical discharge to the heart. (+info)Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. (8/5583)
OBJECTIVE: To compare the efficacy and safety of a single dose of ibutilide, a new class III antiarrhythmic drug, with that of DL-sotalol in terminating chronic atrial fibrillation or flutter in haemodynamically stable patients. DESIGN: Double blind, randomised study. SETTING: 43 European hospitals. PATIENTS: 308 patients (mean age 60 years, 70% men, 48% with heart disease) with sustained atrial fibrillation (n = 251) or atrial flutter (n = 57) (duration three hours to 45 days) were randomised to three groups to receive a 10 minute infusion of 1 mg ibutilide (n = 99), 2 mg ibutilide (n = 106), or 1.5 mg/kg DL-sotalol (n = 103). Infusion was discontinued at termination of the arrhythmia. MAIN OUTCOME MEASURE: Successful conversion of atrial fibrillation or flutter, defined as termination of arrhythmia within one hour of treatment. RESULTS: Both drugs were more effective against atrial flutter than against atrial fibrillation. Ibutilide was superior to DL-sotalol for treating atrial flutter (70% and 56% v 19%), while the high dose of ibutilide was more effective for treating atrial fibrillation than DL-sotalol (44% v 11%) and the lower dose of ibutilide (44% v 20%, p < 0.01). The mean (SD) time to arrhythmia termination was 13 (7) minutes with 2 mg ibutilide, 19 (15) minutes with 1 mg ibutilide, and 25 (17) minutes with DL-sotalol. In all patients, the duration of arrhythmia before treatment was a predictor of arrhythmia termination, although this was less obvious in the group that received 2 mg ibutilide. This dose converted almost 48% of atrial fibrillation that was present for more than 30 days. Concomitant use of digitalis or nifedipine and prolongation of the QTc interval were not predictive of arrhythmia termination. Bradycardia (6.5%) and hypotension (3.7%) were more common side effects with DL-sotalol. Of 211 patients given ibutilide, two (0.9%) who received the higher dose developed polymorphic ventricular tachycardia, one of whom required direct current cardioversion. CONCLUSION: Ibutilide (given in 1 or 2 mg doses over 10 minutes) is highly effective for rapidly terminating persistent atrial fibrillation or atrial flutter. This new class III drug, under monitored conditions, is a potential alternative to currently available cardioversion options. (+info)Atrial fibrillation (A-tre-al fi-bru-la'shun) is a type of abnormal heart rhythm characterized by rapid and irregular beating of the atria, the upper chambers of the heart. In this condition, the electrical signals that coordinate heartbeats don't function properly, causing the atria to quiver instead of contracting effectively. As a result, blood may not be pumped efficiently into the ventricles, which can lead to blood clots, stroke, and other complications. Atrial fibrillation is a common type of arrhythmia and can cause symptoms such as palpitations, shortness of breath, fatigue, and dizziness. It can be caused by various factors, including heart disease, high blood pressure, age, and genetics. Treatment options include medications, electrical cardioversion, and surgical procedures to restore normal heart rhythm.
Catheter ablation is a medical procedure in which specific areas of heart tissue that are causing arrhythmias (irregular heartbeats) are destroyed or ablated using heat energy (radiofrequency ablation), cold energy (cryoablation), or other methods. The procedure involves threading one or more catheters through the blood vessels to the heart, where the tip of the catheter can be used to selectively destroy the problematic tissue. Catheter ablation is often used to treat atrial fibrillation, atrial flutter, and other types of arrhythmias that originate in the heart's upper chambers (atria). It may also be used to treat certain types of arrhythmias that originate in the heart's lower chambers (ventricles), such as ventricular tachycardia.
The goal of catheter ablation is to eliminate or reduce the frequency and severity of arrhythmias, thereby improving symptoms and quality of life. In some cases, it may also help to reduce the risk of stroke and other complications associated with arrhythmias. Catheter ablation is typically performed by a specialist in heart rhythm disorders (electrophysiologist) in a hospital or outpatient setting under local anesthesia and sedation. The procedure can take several hours to complete, depending on the complexity of the arrhythmia being treated.
It's important to note that while catheter ablation is generally safe and effective, it does carry some risks, such as bleeding, infection, damage to nearby structures, and the possibility of recurrent arrhythmias. Patients should discuss the potential benefits and risks of the procedure with their healthcare provider before making a decision about treatment.
The heart atria are the upper chambers of the heart that receive blood from the veins and deliver it to the lower chambers, or ventricles. There are two atria in the heart: the right atrium receives oxygen-poor blood from the body and pumps it into the right ventricle, which then sends it to the lungs to be oxygenated; and the left atrium receives oxygen-rich blood from the lungs and pumps it into the left ventricle, which then sends it out to the rest of the body. The atria contract before the ventricles during each heartbeat, helping to fill the ventricles with blood and prepare them for contraction.
Ventricular Fibrillation (VF) is a type of cardiac arrhythmia, which is an abnormal heart rhythm. In VF, the ventricles, which are the lower chambers of the heart, beat in a rapid and unorganized manner. This results in the heart being unable to pump blood effectively to the rest of the body, leading to immediate circulatory collapse and cardiac arrest if not treated promptly. It is often caused by underlying heart conditions such as coronary artery disease, structural heart problems, or electrolyte imbalances. VF is a medical emergency that requires immediate defibrillation to restore a normal heart rhythm.
Anti-arrhythmia agents are a class of medications used to treat abnormal heart rhythms or arrhythmias. These drugs work by modifying the electrical activity of the heart to restore and maintain a normal heart rhythm. There are several types of anti-arrhythmia agents, including:
1. Sodium channel blockers: These drugs slow down the conduction of electrical signals in the heart, which helps to reduce rapid or irregular heartbeats. Examples include flecainide, propafenone, and quinidine.
2. Beta-blockers: These medications work by blocking the effects of adrenaline on the heart, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include metoprolol, atenolol, and esmolol.
3. Calcium channel blockers: These drugs block the entry of calcium into heart muscle cells, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include verapamil and diltiazem.
4. Potassium channel blockers: These medications work by prolonging the duration of the heart's electrical cycle, which helps to prevent abnormal rhythms. Examples include amiodarone and sotalol.
5. Digoxin: This drug increases the force of heart contractions and slows down the heart rate, which can help to restore a normal rhythm in certain types of arrhythmias.
It's important to note that anti-arrhythmia agents can have significant side effects and should only be prescribed by a healthcare professional who has experience in managing arrhythmias. Close monitoring is necessary to ensure the medication is working effectively and not causing any adverse effects.
Pulmonary veins are blood vessels that carry oxygenated blood from the lungs to the left atrium of the heart. There are four pulmonary veins in total, two from each lung, and they are the only veins in the body that carry oxygen-rich blood. The oxygenated blood from the pulmonary veins is then pumped by the left ventricle to the rest of the body through the aorta. Any blockage or damage to the pulmonary veins can lead to various cardiopulmonary conditions, such as pulmonary hypertension and congestive heart failure.
Electric countershock, also known as defibrillation, is a medical procedure that uses an electric current to restore normal heart rhythm in certain types of cardiac arrhythmias, such as ventricular fibrillation or pulseless ventricular tachycardia. The procedure involves delivering a therapeutic dose of electrical energy to the heart through electrodes placed on the chest wall or directly on the heart. This electric current helps to depolarize a large number of cardiac cells simultaneously, which can help to interrupt the abnormal electrical activity in the heart and allow the normal conduction system to regain control and restore a normal rhythm. Electric countershock is typically delivered using an automated external defibrillator (AED) or a manual defibrillator, and it is a critical component of advanced cardiac life support (ACLS).
Warfarin is a anticoagulant medication that works by inhibiting the vitamin K-dependent activation of several coagulation factors (factors II, VII, IX, and X). This results in prolonged clotting times and reduced thrombus formation. It is commonly used to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Warfarin is also known by its brand names Coumadin and Jantoven.
It's important to note that warfarin has a narrow therapeutic index, meaning that the difference between an effective dose and a toxic one is small. Therefore, it requires careful monitoring of the patient's coagulation status through regular blood tests (INR) to ensure that the dosage is appropriate and to minimize the risk of bleeding complications.
Atrial flutter is a type of abnormal heart rhythm or arrhythmia that originates in the atria - the upper chambers of the heart. In atrial flutter, the atria beat too quickly, usually between 250 and 350 beats per minute, which is much faster than the normal resting rate of 60 to 100 beats per minute.
This rapid beating causes the atria to quiver or "flutter" instead of contracting effectively. As a result, blood may not be pumped efficiently into the ventricles - the lower chambers of the heart - which can lead to reduced cardiac output and symptoms such as palpitations, shortness of breath, fatigue, dizziness, or chest discomfort.
Atrial flutter is often caused by underlying heart conditions, such as coronary artery disease, hypertension, valvular heart disease, or congenital heart defects. It can also be a complication of cardiac surgery or other medical procedures. In some cases, atrial flutter may occur without any apparent underlying cause, which is known as lone atrial flutter.
Treatment for atrial flutter typically involves medications to control the heart rate and rhythm, electrical cardioversion to restore a normal heart rhythm, or catheter ablation to destroy the abnormal electrical pathways in the heart that are causing the arrhythmia. In some cases, surgical intervention may be necessary to treat atrial flutter.
Anticoagulants are a class of medications that work to prevent the formation of blood clots in the body. They do this by inhibiting the coagulation cascade, which is a series of chemical reactions that lead to the formation of a clot. Anticoagulants can be given orally, intravenously, or subcutaneously, depending on the specific drug and the individual patient's needs.
There are several different types of anticoagulants, including:
1. Heparin: This is a naturally occurring anticoagulant that is often used in hospitalized patients who require immediate anticoagulation. It works by activating an enzyme called antithrombin III, which inhibits the formation of clots.
2. Low molecular weight heparin (LMWH): LMWH is a form of heparin that has been broken down into smaller molecules. It has a longer half-life than standard heparin and can be given once or twice daily by subcutaneous injection.
3. Direct oral anticoagulants (DOACs): These are newer oral anticoagulants that work by directly inhibiting specific clotting factors in the coagulation cascade. Examples include apixaban, rivaroxaban, and dabigatran.
4. Vitamin K antagonists: These are older oral anticoagulants that work by inhibiting the action of vitamin K, which is necessary for the formation of clotting factors. Warfarin is an example of a vitamin K antagonist.
Anticoagulants are used to prevent and treat a variety of conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation, and prosthetic heart valve thrombosis. It is important to note that anticoagulants can increase the risk of bleeding, so they must be used with caution and regular monitoring of blood clotting times may be required.
Electrocardiography (ECG or EKG) is a medical procedure that records the electrical activity of the heart. It provides a graphic representation of the electrical changes that occur during each heartbeat. The resulting tracing, called an electrocardiogram, can reveal information about the heart's rate and rhythm, as well as any damage to its cells or abnormalities in its conduction system.
During an ECG, small electrodes are placed on the skin of the chest, arms, and legs. These electrodes detect the electrical signals produced by the heart and transmit them to a machine that amplifies and records them. The procedure is non-invasive, painless, and quick, usually taking only a few minutes.
ECGs are commonly used to diagnose and monitor various heart conditions, including arrhythmias, coronary artery disease, heart attacks, and electrolyte imbalances. They can also be used to evaluate the effectiveness of certain medications or treatments.
Electrophysiologic techniques, cardiac, refer to medical procedures used to study the electrical activities and conduction systems of the heart. These techniques involve the insertion of electrode catheters into the heart through blood vessels under fluoroscopic guidance to record and stimulate electrical signals. The information obtained from these studies can help diagnose and evaluate various cardiac arrhythmias, determine the optimal treatment strategy, and assess the effectiveness of therapies such as ablation or implantable devices.
The electrophysiologic study (EPS) is a type of cardiac electrophysiologic technique that involves the measurement of electrical signals from different regions of the heart to evaluate its conduction system's function. The procedure can help identify the location of abnormal electrical pathways responsible for arrhythmias and determine the optimal treatment strategy, such as catheter ablation or medication therapy.
Cardiac electrophysiologic techniques are also used in device implantation procedures, such as pacemaker or defibrillator implantation, to ensure proper placement and function of the devices. These techniques can help program and test the devices to optimize their settings for each patient's needs.
In summary, cardiac electrophysiologic techniques are medical procedures used to study and manipulate the electrical activities of the heart, helping diagnose and treat various arrhythmias and other cardiac conditions.
The atrial appendage, also known as the left atrial appendage (LAA), is a small, ear-shaped structure that is located on the upper left chamber of the heart (left atrium). It has a unique muscular structure and plays a role in the normal functioning of the heart. However, it is best known for its association with atrial fibrillation, a common type of irregular heart rhythm. In people with atrial fibrillation, blood clots can form in the LAA, which can then travel to other parts of the body and cause strokes. For this reason, one treatment option for atrial fibrillation is to close off or remove the LAA to reduce the risk of stroke.
Amiodarone is a Class III antiarrhythmic medication used to treat and prevent various types of irregular heart rhythms (arrhythmias). It works by stabilizing the electrical activity of the heart and slowing down the nerve impulses in the heart tissue. Amiodarone is available in oral tablet and injection forms.
The medical definition of 'Amiodarone' is:
A benzofuran derivative with Class III antiarrhythmic properties, used for the treatment of ventricular arrhythmias. It has a relatively slow onset of action and is therefore not useful in acute situations. Additionally, it has negative inotropic effects and may exacerbate heart failure. The most serious adverse effect is pulmonary fibrosis, which occurs in approximately 1-2% of patients. Other important side effects include corneal microdeposits, hepatotoxicity, thyroid dysfunction, and photosensitivity. Amiodarone has a very long half-life (approximately 50 days) due to its extensive tissue distribution. It is metabolized by the liver and excreted in bile and urine.
Sources:
1. UpToDate - Amiodarone use in adults: Indications, dosing, and adverse effects.
2. Micromedex - Amiodarone.
3. Drugs.com - Amiodarone.
Artificial cardiac pacing is a medical procedure that involves the use of an artificial device to regulate and stimulate the contraction of the heart muscle. This is often necessary when the heart's natural pacemaker, the sinoatrial node, is not functioning properly and the heart is beating too slowly or irregularly.
The artificial pacemaker consists of a small generator that produces electrical impulses and leads that are positioned in the heart to transmit the impulses. The generator is typically implanted just under the skin in the chest, while the leads are inserted into the heart through a vein.
There are different types of artificial cardiac pacing systems, including single-chamber pacemakers, which stimulate either the right atrium or right ventricle, and dual-chamber pacemakers, which stimulate both chambers of the heart. Some pacemakers also have additional features that allow them to respond to changes in the body's needs, such as during exercise or sleep.
Artificial cardiac pacing is a safe and effective treatment for many people with abnormal heart rhythms, and it can significantly improve their quality of life and longevity.
The heart conduction system is a group of specialized cardiac muscle cells that generate and conduct electrical impulses to coordinate the contraction of the heart chambers. The main components of the heart conduction system include:
1. Sinoatrial (SA) node: Also known as the sinus node, it is located in the right atrium near the entrance of the superior vena cava and functions as the primary pacemaker of the heart. It sets the heart rate by generating electrical impulses at regular intervals.
2. Atrioventricular (AV) node: Located in the interatrial septum, near the opening of the coronary sinus, it serves as a relay station for electrical signals between the atria and ventricles. The AV node delays the transmission of impulses to allow the atria to contract before the ventricles.
3. Bundle of His: A bundle of specialized cardiac muscle fibers that conducts electrical impulses from the AV node to the ventricles. It divides into two main branches, the right and left bundle branches, which further divide into smaller Purkinje fibers.
4. Right and left bundle branches: These are extensions of the Bundle of His that transmit electrical impulses to the respective right and left ventricular myocardium. They consist of specialized conducting tissue with large diameters and minimal resistance, allowing for rapid conduction of electrical signals.
5. Purkinje fibers: Fine, branching fibers that arise from the bundle branches and spread throughout the ventricular myocardium. They are responsible for transmitting electrical impulses to the working cardiac muscle cells, triggering coordinated ventricular contraction.
In summary, the heart conduction system is a complex network of specialized muscle cells responsible for generating and conducting electrical signals that coordinate the contraction of the atria and ventricles, ensuring efficient blood flow throughout the body.
Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.
Thromboembolism is a medical condition that refers to the obstruction of a blood vessel by a thrombus (blood clot) that has formed elsewhere in the body and then been transported by the bloodstream to a narrower vessel, where it becomes lodged. This process can occur in various parts of the body, leading to different types of thromboembolisms:
1. Deep Vein Thrombosis (DVT): A thrombus forms in the deep veins, usually in the legs or pelvis, and then breaks off and travels to the lungs, causing a pulmonary embolism.
2. Pulmonary Embolism (PE): A thrombus formed elsewhere, often in the deep veins of the legs, dislodges and travels to the lungs, blocking one or more pulmonary arteries. This can lead to shortness of breath, chest pain, and potentially life-threatening complications if not treated promptly.
3. Cerebral Embolism: A thrombus formed in another part of the body, such as the heart or carotid artery, dislodges and travels to the brain, causing a stroke or transient ischemic attack (TIA).
4. Arterial Thromboembolism: A thrombus forms in an artery and breaks off, traveling to another part of the body and blocking blood flow to an organ or tissue, leading to potential damage or loss of function. Examples include mesenteric ischemia (intestinal damage due to blocked blood flow) and retinal artery occlusion (vision loss due to blocked blood flow in the eye).
Prevention, early detection, and appropriate treatment are crucial for managing thromboembolism and reducing the risk of severe complications.
A stroke, also known as cerebrovascular accident (CVA), is a serious medical condition that occurs when the blood supply to part of the brain is interrupted or reduced, leading to deprivation of oxygen and nutrients to brain cells. This can result in the death of brain tissue and cause permanent damage or temporary impairment to cognitive functions, speech, memory, movement, and other body functions controlled by the affected area of the brain.
Strokes can be caused by either a blockage in an artery that supplies blood to the brain (ischemic stroke) or the rupture of a blood vessel in the brain (hemorrhagic stroke). A transient ischemic attack (TIA), also known as a "mini-stroke," is a temporary disruption of blood flow to the brain that lasts only a few minutes and does not cause permanent damage.
Symptoms of a stroke may include sudden weakness or numbness in the face, arm, or leg; difficulty speaking or understanding speech; vision problems; loss of balance or coordination; severe headache with no known cause; and confusion or disorientation. Immediate medical attention is crucial for stroke patients to receive appropriate treatment and prevent long-term complications.
The refractory period, electrophysiological, refers to the time interval during which a cardiac or neural cell is unable to respond to a new stimulus immediately after an action potential has been generated. This period is divided into two phases: the absolute refractory period and the relative refractory period.
During the absolute refractory period, the cell cannot be re-stimulated, regardless of the strength of the stimulus, due to the rapid inactivation of voltage-gated sodium channels that are responsible for the rapid depolarization during an action potential. This phase is crucial for maintaining the unidirectional conduction of electrical impulses and preventing the occurrence of re-entry circuits, which can lead to life-threatening arrhythmias in the heart or hyperexcitability in neural tissue.
The relative refractory period follows the absolute refractory period and is characterized by a reduced excitability of the cell. During this phase, a stronger than normal stimulus is required to elicit an action potential due to the slower recovery of voltage-gated sodium channels and the partial activation of potassium channels, which promote repolarization. The duration of both the absolute and relative refractory periods varies depending on the cell type, its physiological state, and other factors such as temperature and pH.
In summary, the electrophysiological refractory period is a fundamental property of excitable cells that ensures proper electrical signaling and prevents uncontrolled excitation or re-entry circuits.
Paroxysmal Tachycardia is a type of arrhythmia (abnormal heart rhythm) characterized by rapid and abrupt onset and offset of episodes of tachycardia, which are faster than normal heart rates. The term "paroxysmal" refers to the sudden and recurring nature of these episodes.
Paroxysmal Tachycardia can occur in various parts of the heart, including the atria (small upper chambers) or ventricles (larger lower chambers). The two most common types are Atrial Paroxysmal Tachycardia (APT) and Ventricular Paroxysmal Tachycardia (VPT).
APT is more common and typically results in a rapid heart rate of 100-250 beats per minute. It usually begins and ends suddenly, lasting for seconds to hours. APT can cause symptoms such as palpitations, lightheadedness, shortness of breath, chest discomfort, or anxiety.
VPT is less common but more serious because it involves the ventricles, which are responsible for pumping blood to the rest of the body. VPT can lead to decreased cardiac output and potentially life-threatening conditions such as syncope (fainting) or even cardiac arrest.
Treatment options for Paroxysmal Tachycardia depend on the underlying cause, severity, and frequency of symptoms. These may include lifestyle modifications, medications, cardioversion (electrical shock to restore normal rhythm), catheter ablation (destroying problematic heart tissue), or implantable devices such as pacemakers or defibrillators.
Atrial function in a medical context refers to the role and performance of the two upper chambers of the heart, known as the atria. The main functions of the atria are to receive blood from the veins and help pump it into the ventricles, which are the lower pumping chambers of the heart.
The atria contract in response to electrical signals generated by the sinoatrial node, which is the heart's natural pacemaker. This contraction helps to fill the ventricles with blood before they contract and pump blood out to the rest of the body. Atrial function can be assessed through various diagnostic tests, such as echocardiograms or electrocardiograms (ECGs), which can help identify any abnormalities in atrial structure or electrical activity that may affect heart function.
Left atrial function refers to the role and performance of the left atrium in the heart. The left atrium is the upper chamber on the left side of the heart that receives oxygenated blood from the lungs via the pulmonary veins and then contracts to help pump it into the left ventricle, which is the lower chamber that pumps blood out to the rest of the body.
The main functions of the left atrium include:
1. Receiving oxygen-rich blood from the lungs: The left atrium receives oxygenated blood from the pulmonary veins and acts as a reservoir for this blood before it is pumped into the left ventricle.
2. Contracting to help pump blood into the left ventricle: During atrial contraction, also known as atrial kick, the left atrium contracts and helps push blood into the left ventricle, increasing the amount of blood that can be ejected with each heartbeat.
3. Relaxing to receive more blood: Between heartbeats, the left atrium relaxes and fills up with more oxygenated blood from the lungs.
4. Contributing to heart rate regulation: The left atrium contains specialized cells called pacemaker cells that can help regulate the heart rate by initiating electrical impulses that trigger heart contractions.
Left atrial function is crucial for maintaining efficient cardiac output and overall cardiovascular health. Various conditions, such as heart failure, atrial fibrillation, and hypertension, can negatively impact left atrial function and contribute to the development of complications like stroke and reduced exercise tolerance.
Recurrence, in a medical context, refers to the return of symptoms or signs of a disease after a period of improvement or remission. It indicates that the condition has not been fully eradicated and may require further treatment. Recurrence is often used to describe situations where a disease such as cancer comes back after initial treatment, but it can also apply to other medical conditions. The likelihood of recurrence varies depending on the type of disease and individual patient factors.
Atrial premature complexes (APCs or APCTs) are extra heartbeats that originate in the atria, which are the upper chambers of the heart. These early beats disrupt the normal rhythm and cause a premature contraction before the next scheduled beat. APCs can sometimes be felt as a "skipped" beat or palpitation. They are usually benign and do not require treatment unless they occur frequently or are associated with underlying heart disease.
Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.
In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.
The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.
Propafenone is an antiarrhythmic medication used to treat certain types of irregular heartbeats (such as atrial fibrillation, paroxysmal supraventricular tachycardia). It works by blocking certain electrical signals in the heart to help it beat regularly. Propafenone belongs to a class of drugs known as Class IC antiarrhythmics.
It is important to note that this definition provides an overview of what propafenone is and how it is used, but it does not cover all possible uses, precautions, side effects, and interactions related to the drug. For more detailed information about propafenone, including its specific indications, contraindications, and potential adverse effects, consult a reliable medical reference or speak with a healthcare professional.
Ambulatory electrocardiography, also known as ambulatory ECG or Holter monitoring, is a non-invasive method of recording the electrical activity of the heart over an extended period of time (typically 24 hours or more) while the patient goes about their daily activities. The device used to record the ECG is called a Holter monitor, which consists of a small, portable recorder that is attached to the patient's chest with electrodes.
The recorded data provides information on any abnormalities in the heart's rhythm or electrical activity during different stages of activity and rest, allowing healthcare providers to diagnose and evaluate various cardiac conditions such as arrhythmias, ischemia, and infarction. The ability to monitor the heart's activity over an extended period while the patient performs their normal activities provides valuable information that may not be captured during a standard ECG, which only records the heart's electrical activity for a few seconds.
In summary, ambulatory electrocardiography is a diagnostic tool used to evaluate the electrical activity of the heart over an extended period, allowing healthcare providers to diagnose and manage various cardiac conditions.
Body Surface Potential Mapping (BSPM) is a non-invasive medical technique used to record and analyze the electrical activity of the heart from the surface of the body. It involves placing multiple electrodes on the skin of the chest, back, and limbs to measure the potential differences between these points during each heartbeat. This information is then used to create a detailed, visual representation of the electrical activation pattern of the heart, which can help in the diagnosis and evaluation of various cardiac disorders such as arrhythmias, myocardial infarction, and ventricular hypertrophy.
The BSPM technique provides high-resolution spatial and temporal information about the cardiac electrical activity, making it a valuable tool for both clinical and research purposes. It can help identify the origin and spread of abnormal electrical signals in the heart, which is crucial for determining appropriate treatment strategies. Overall, Body Surface Potential Mapping is an important diagnostic modality that offers unique insights into the electrical functioning of the heart.
Beta-alanine is a non-essential amino acid, which means that it is not required in the diet because the body can produce it from other amino acids. It is produced in the liver and is also found in some foods such as meat, poultry, and fish.
Beta-alanine plays a role in the production of carnosine, a dipeptide molecule that helps to regulate muscle pH and improve muscle function during high-intensity exercise. When muscles contract during intense exercise, they produce hydrogen ions, which can cause the muscle pH to decrease (become more acidic), leading to fatigue and reduced muscle function. Carnosine acts as a buffer against this acidity, helping to maintain optimal muscle pH levels and improve performance during high-intensity exercise.
Beta-alanine supplements have been shown to increase carnosine levels in muscles, which may lead to improved athletic performance, particularly in activities that require short bursts of intense effort, such as weightlifting or sprinting. However, more research is needed to fully understand the effects and potential benefits of beta-alanine supplementation.
It's important to note that while beta-alanine supplements are generally considered safe for most people, they can cause a tingling sensation in the skin (paresthesia) when taken in high doses. This is a harmless side effect and typically subsides within an hour or so of taking the supplement.
Sotalol is a non-selective beta blocker and class III antiarrhythmic drug. It works by blocking the action of certain natural substances in your body, such as adrenaline, on the heart. This helps to decrease the heart's workload, slow the heart rate, and regulate certain types of irregular heartbeats (such as atrial fibrillation).
Sotalol is used to treat various types of irregular heartbeats (atrial fibrillation/flutter, ventricular tachycardia) and may also be used to help maintain a normal heart rhythm after a heart attack. It is important to note that Sotalol should only be prescribed by a healthcare professional who has experience in treating heart rhythm disorders.
This medical definition is based on the information provided by the National Library of Medicine (NLM).
Flecainide is an antiarrhythmic medication used to regularize abnormal heart rhythms, specifically certain types of irregular heartbeats called ventricular arrhythmias and paroxysmal atrial tachycardia/atrial fibrillation. It works by blocking sodium channels in the heart, which helps to slow down the conduction of electrical signals and reduces the likelihood of erratic heart rhythms.
Flecainide is available in oral forms such as tablets or capsules and is typically prescribed under the supervision of a healthcare professional experienced in managing heart rhythm disorders. It's important to note that flecainide can have serious side effects, including increasing the risk of dangerous arrhythmias in some patients, so it should only be used under close medical monitoring.
This definition is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. If you have any questions about your medications or health conditions, please consult with your healthcare provider.
Medical Definition:
"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.
An artificial pacemaker is a medical device that uses electrical impulses to regulate the beating of the heart. It is typically used when the heart's natural pacemaker, the sinoatrial node, is not functioning properly and the heart rate is too slow or irregular. The pacemaker consists of a small generator that contains a battery and electronic circuits, which are connected to one or more electrodes that are placed in the heart.
The generator sends electrical signals through the electrodes to stimulate the heart muscle and cause it to contract, thereby maintaining a regular heart rhythm. Artificial pacemakers can be programmed to deliver electrical impulses at a specific rate or in response to the body's needs. They are typically implanted in the chest during a surgical procedure and can last for many years before needing to be replaced.
Artificial pacemakers are an effective treatment for various types of bradycardia, which is a heart rhythm disorder characterized by a slow heart rate. Pacemakers can significantly improve symptoms associated with bradycardia, such as fatigue, dizziness, shortness of breath, and fainting spells.
Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.
The atrioventricular (AV) node is a critical part of the electrical conduction system of the heart. It is a small cluster of specialized cardiac muscle cells located in the lower interatrial septum, near the opening of the coronary sinus. The AV node receives electrical impulses from the sinoatrial node (the heart's natural pacemaker) via the internodal pathways and delays their transmission for a brief period before transmitting them to the bundle of His and then to the ventricles. This delay allows the atria to contract and empty their contents into the ventricles before the ventricles themselves contract, ensuring efficient pumping of blood throughout the body.
The AV node plays an essential role in maintaining a normal heart rhythm, as it can also function as a backup pacemaker if the sinoatrial node fails to generate impulses. However, certain heart conditions or medications can affect the AV node's function and lead to abnormal heart rhythms, such as atrioventricular block or atrial tachycardia.
Sick Sinus Syndrome (SSS) is a term used to describe a group of abnormal heart rhythm disturbances that originates in the sinoatrial node (the natural pacemaker of the heart). This syndrome is characterized by impaired functioning of the sinoatrial node, resulting in various abnormalities such as sinus bradycardia (abnormally slow heart rate), sinus arrest (complete cessation of sinus node activity), and/or sinoatrial exit block (failure of the electrical impulse to leave the sinus node and spread to the atria).
People with SSS may experience symptoms such as palpitations, dizziness, fatigue, shortness of breath, or syncope (fainting) due to inadequate blood supply to the brain caused by slow heart rate. The diagnosis of SSS is typically made based on the patient's symptoms and the results of an electrocardiogram (ECG), Holter monitoring, or event recorder that shows evidence of abnormal sinus node function. Treatment options for SSS may include lifestyle modifications, medications, or implantation of a pacemaker to regulate the heart rate.
In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.
For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.
Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.
Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.
The International Normalized Ratio (INR) is a standardized measurement of the prothrombin time (PT), which is the time it takes for blood to clot. The INR is used to monitor and regulate the effects of anticoagulant medications, such as warfarin, that affect the blood's ability to clot.
The INR is calculated by dividing the patient's PT by a control value (the PT of normal, healthy blood), raised to the power of a sensitivity factor called the International Sensitivity Index (ISI). The ISI is specific to the thromboplastin reagent used in the PT assay.
The INR provides a consistent and comparable way to monitor anticoagulation therapy across different laboratories, regardless of the thromboplastin reagent used. This helps ensure that patients receive appropriate doses of anticoagulant medications and reduces the risk of bleeding or clotting complications.
In general, an INR range of 2.0 to 3.0 is recommended for most people taking anticoagulants for conditions such as atrial fibrillation, deep vein thrombosis, or pulmonary embolism. However, the target INR range may vary depending on individual patient factors and medical indications.
An embolism is a medical condition that occurs when a substance, such as a blood clot or an air bubble, blocks a blood vessel. This can happen in any part of the body, but it is particularly dangerous when it affects the brain (causing a stroke) or the lungs (causing a pulmonary embolism). Embolisms can cause serious harm by preventing oxygen and nutrients from reaching the tissues and organs that need them. They are often the result of underlying medical conditions, such as heart disease or deep vein thrombosis, and may require immediate medical attention to prevent further complications.
Transesophageal echocardiography (TEE) is a type of echocardiogram, which is a medical test that uses sound waves to create detailed images of the heart. In TEE, a special probe containing a transducer is passed down the esophagus (the tube that connects the mouth to the stomach) to obtain views of the heart from behind. This allows for more detailed images of the heart structures and function compared to a standard echocardiogram, which uses a probe placed on the chest. TEE is often used in patients with poor image quality from a standard echocardiogram or when more detailed images are needed to diagnose or monitor certain heart conditions. It is typically performed by a trained cardiologist or sonographer under the direction of a cardiologist.
Heart rate is the number of heartbeats per unit of time, often expressed as beats per minute (bpm). It can vary significantly depending on factors such as age, physical fitness, emotions, and overall health status. A resting heart rate between 60-100 bpm is generally considered normal for adults, but athletes and individuals with high levels of physical fitness may have a resting heart rate below 60 bpm due to their enhanced cardiovascular efficiency. Monitoring heart rate can provide valuable insights into an individual's health status, exercise intensity, and response to various treatments or interventions.
Cryosurgery is a medical procedure that uses extreme cold, such as liquid nitrogen or argon gas, to destroy abnormal or unwanted tissue. The intense cold causes the water inside the cells to freeze and form ice crystals, which can rupture the cell membrane and cause the cells to die. Cryosurgery is often used to treat a variety of conditions including skin growths such as warts and tumors, precancerous lesions, and some types of cancer. The procedure is typically performed in a doctor's office or outpatient setting and may require local anesthesia.
Wolff-Parkinson-White (WPW) Syndrome is a heart condition characterized by the presence of an accessory pathway or abnormal electrical connection between the atria (the upper chambers of the heart) and ventricles (the lower chambers of the heart). This accessory pathway allows electrical impulses to bypass the normal conduction system, leading to a shorter PR interval and a "delta wave" on the electrocardiogram (ECG), which is the hallmark of WPW Syndrome.
Individuals with WPW Syndrome may experience no symptoms or may have palpitations, rapid heartbeat (tachycardia), or episodes of atrial fibrillation. In some cases, WPW Syndrome can lead to more serious heart rhythm disturbances and may require treatment, such as medication, catheter ablation, or in rare cases, surgery.
It is important to note that not all individuals with WPW Syndrome will experience symptoms or complications, and many people with this condition can lead normal, active lives with appropriate monitoring and management.
Cardiac arrhythmias are abnormal heart rhythms that result from disturbances in the electrical conduction system of the heart. The heart's normal rhythm is controlled by an electrical signal that originates in the sinoatrial (SA) node, located in the right atrium. This signal travels through the atrioventricular (AV) node and into the ventricles, causing them to contract and pump blood throughout the body.
An arrhythmia occurs when there is a disruption in this electrical pathway or when the heart's natural pacemaker produces an abnormal rhythm. This can cause the heart to beat too fast (tachycardia), too slow (bradycardia), or irregularly.
There are several types of cardiac arrhythmias, including:
1. Atrial fibrillation: A rapid and irregular heartbeat that starts in the atria (the upper chambers of the heart).
2. Atrial flutter: A rapid but regular heartbeat that starts in the atria.
3. Supraventricular tachycardia (SVT): A rapid heartbeat that starts above the ventricles, usually in the atria or AV node.
4. Ventricular tachycardia: A rapid and potentially life-threatening heart rhythm that originates in the ventricles.
5. Ventricular fibrillation: A chaotic and disorganized electrical activity in the ventricles, which can be fatal if not treated immediately.
6. Heart block: A delay or interruption in the conduction of electrical signals from the atria to the ventricles.
Cardiac arrhythmias can cause various symptoms, such as palpitations, dizziness, shortness of breath, chest pain, and fatigue. In some cases, they may not cause any symptoms and go unnoticed. However, if left untreated, certain types of arrhythmias can lead to serious complications, including stroke, heart failure, or even sudden cardiac death.
Treatment for cardiac arrhythmias depends on the type, severity, and underlying causes. Options may include lifestyle changes, medications, cardioversion (electrical shock therapy), catheter ablation, implantable devices such as pacemakers or defibrillators, and surgery. It is essential to consult a healthcare professional for proper evaluation and management of cardiac arrhythmias.
Bepridil is a calcium channel blocker medication that is used to treat angina (chest pain) and certain types of irregular heart rhythms. It works by relaxing the blood vessels and increasing the supply of oxygen and blood to the heart.
Here is the medical definition of Bepridil:
Bepridil is a non-dihydropyridine calcium channel blocker that selectively inhibits the L-type calcium channels in cardiac and smooth muscle cells, resulting in vasodilation, negative inotropic and chronotropic effects on the heart. It is used in the management of chronic stable angina pectoris and certain types of arrhythmias. The most common side effects include dizziness, headache, nausea, and constipation. Bepridil has a negative inotropic effect and should be used with caution in patients with heart failure or reduced left ventricular function. It is also metabolized by the cytochrome P450 system and can interact with other medications that are metabolized by this pathway.
Tachycardia is a medical term that refers to an abnormally rapid heart rate, often defined as a heart rate greater than 100 beats per minute in adults. It can occur in either the atria (upper chambers) or ventricles (lower chambers) of the heart. Different types of tachycardia include supraventricular tachycardia (SVT), atrial fibrillation, atrial flutter, and ventricular tachycardia.
Tachycardia can cause various symptoms such as palpitations, shortness of breath, dizziness, lightheadedness, chest discomfort, or syncope (fainting). In some cases, tachycardia may not cause any symptoms and may only be detected during a routine physical examination or medical test.
The underlying causes of tachycardia can vary widely, including heart disease, electrolyte imbalances, medications, illicit drug use, alcohol abuse, smoking, stress, anxiety, and other medical conditions. In some cases, the cause may be unknown. Treatment for tachycardia depends on the underlying cause, type, severity, and duration of the arrhythmia.
Tachycardia is a heart rate that is faster than normal when resting. In adults, a normal resting heart rate is typically between 60 and 100 beats per minute (bpm). Tachycardia is generally considered to be a heart rate of more than 100 bpm.
Ectopic atrial tachycardia (EAT) is a type of supraventricular tachycardia (SVT), which means that the abnormal rapid heartbeats originate in the atria, the upper chambers of the heart. EAT is caused by an ectopic focus, or an abnormal electrical focus outside of the sinoatrial node (the heart's natural pacemaker). This ectopic focus can be located in one of the pulmonary veins or in other atrial tissue.
EAT may present with symptoms such as palpitations, lightheadedness, shortness of breath, chest discomfort, or syncope (fainting). In some cases, EAT may not cause any symptoms and can be an incidental finding on an electrocardiogram (ECG) or Holter monitor.
The diagnosis of EAT is typically made based on the ECG findings, which show a regular narrow QRS complex tachycardia with P waves that are inverted in the inferior leads and often dissociated from the QRS complexes. Treatment options for EAT include observation, pharmacologic therapy, cardioversion, or catheter ablation.
Digoxin is a medication that belongs to a class of drugs called cardiac glycosides. It is used to treat various heart conditions, such as heart failure and atrial fibrillation, by helping the heart beat stronger and more regularly. Digoxin works by inhibiting the sodium-potassium pump in heart muscle cells, which leads to an increase in intracellular calcium and a strengthening of heart contractions. It is important to monitor digoxin levels closely, as too much can lead to toxicity and serious side effects.
Hemorrhage is defined in the medical context as an excessive loss of blood from the circulatory system, which can occur due to various reasons such as injury, surgery, or underlying health conditions that affect blood clotting or the integrity of blood vessels. The bleeding may be internal, external, visible, or concealed, and it can vary in severity from minor to life-threatening, depending on the location and extent of the bleeding. Hemorrhage is a serious medical emergency that requires immediate attention and treatment to prevent further blood loss, organ damage, and potential death.
Cardiac surgical procedures are operations that are performed on the heart or great vessels (the aorta and vena cava) by cardiothoracic surgeons. These surgeries are often complex and require a high level of skill and expertise. Some common reasons for cardiac surgical procedures include:
1. Coronary artery bypass grafting (CABG): This is a surgery to improve blood flow to the heart in patients with coronary artery disease. During the procedure, a healthy blood vessel from another part of the body is used to create a detour around the blocked or narrowed portion of the coronary artery.
2. Valve repair or replacement: The heart has four valves that control blood flow through and out of the heart. If one or more of these valves become damaged or diseased, they may need to be repaired or replaced. This can be done using artificial valves or valves from animal or human donors.
3. Aneurysm repair: An aneurysm is a weakened area in the wall of an artery that can bulge out and potentially rupture. If an aneurysm occurs in the aorta, it may require surgical repair to prevent rupture.
4. Heart transplantation: In some cases, heart failure may be so severe that a heart transplant is necessary. This involves removing the diseased heart and replacing it with a healthy donor heart.
5. Arrhythmia surgery: Certain types of abnormal heart rhythms (arrhythmias) may require surgical treatment. One such procedure is called the Maze procedure, which involves creating a pattern of scar tissue in the heart to disrupt the abnormal electrical signals that cause the arrhythmia.
6. Congenital heart defect repair: Some people are born with structural problems in their hearts that require surgical correction. These may include holes between the chambers of the heart or abnormal blood vessels.
Cardiac surgical procedures carry risks, including bleeding, infection, stroke, and death. However, for many patients, these surgeries can significantly improve their quality of life and longevity.
A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.
Right atrial function refers to the role and performance of the right atrium in the heart. The right atrium is one of the four chambers of the heart and is responsible for receiving deoxygenated blood from the body via the superior and inferior vena cava. It then contracts to help pump the blood into the right ventricle, which subsequently sends it to the lungs for oxygenation.
Right atrial function can be assessed through various methods, including echocardiography, cardiac magnetic resonance imaging (MRI), and electrocardiogram (ECG). Abnormalities in right atrial function may indicate underlying heart conditions such as right-sided heart failure, atrial fibrillation, or other cardiovascular diseases. Proper evaluation and monitoring of right atrial function are essential for effective diagnosis, treatment, and management of these conditions.
I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.
If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.
Risk assessment in the medical context refers to the process of identifying, evaluating, and prioritizing risks to patients, healthcare workers, or the community related to healthcare delivery. It involves determining the likelihood and potential impact of adverse events or hazards, such as infectious diseases, medication errors, or medical devices failures, and implementing measures to mitigate or manage those risks. The goal of risk assessment is to promote safe and high-quality care by identifying areas for improvement and taking action to minimize harm.
Sinus arrhythmia is a type of heart rhythm disorder (arrhythmia) where the normal rhythm generated by the sinus node in the heart varies in rate or pattern. The sinus node is the natural pacemaker of the heart and usually sets a steady pace for heartbeats. However, in sinus arrhythmia, the heart rate may speed up or slow down abnormally during breathing in (inspiration) or breathing out (expiration).
When the heart rate increases during inspiration, it is called "inspiratory sinus arrhythmia," and when the heart rate decreases during expiration, it is called "expiratory sinus arrhythmia." Most people experience a mild form of inspiratory sinus arrhythmia, which is considered normal, especially in children and young adults.
However, if the variation in heart rate is significant or accompanied by symptoms such as palpitations, dizziness, shortness of breath, or chest discomfort, it may require medical evaluation and treatment. Sinus arrhythmia can be caused by various factors, including lung disease, heart disease, electrolyte imbalances, or the use of certain medications.
Supraventricular tachycardia (SVT) is a rapid heart rhythm that originates above the ventricles (the lower chambers of the heart). This type of tachycardia includes atrial tachycardia, atrioventricular nodal reentrant tachycardia (AVNRT), and atrioventricular reentrant tachycardia (AVRT). SVT usually causes a rapid heartbeat that starts and stops suddenly, and may not cause any other symptoms. However, some people may experience palpitations, shortness of breath, chest discomfort, dizziness, or fainting. SVT is typically diagnosed through an electrocardiogram (ECG) or Holter monitor, and can be treated with medications, cardioversion, or catheter ablation.
In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.
Echocardiography is a medical procedure that uses sound waves to produce detailed images of the heart's structure, function, and motion. It is a non-invasive test that can help diagnose various heart conditions, such as valve problems, heart muscle damage, blood clots, and congenital heart defects.
During an echocardiogram, a transducer (a device that sends and receives sound waves) is placed on the chest or passed through the esophagus to obtain images of the heart. The sound waves produced by the transducer bounce off the heart structures and return to the transducer, which then converts them into electrical signals that are processed to create images of the heart.
There are several types of echocardiograms, including:
* Transthoracic echocardiography (TTE): This is the most common type of echocardiogram and involves placing the transducer on the chest.
* Transesophageal echocardiography (TEE): This type of echocardiogram involves passing a specialized transducer through the esophagus to obtain images of the heart from a closer proximity.
* Stress echocardiography: This type of echocardiogram is performed during exercise or medication-induced stress to assess how the heart functions under stress.
* Doppler echocardiography: This type of echocardiogram uses sound waves to measure blood flow and velocity in the heart and blood vessels.
Echocardiography is a valuable tool for diagnosing and managing various heart conditions, as it provides detailed information about the structure and function of the heart. It is generally safe, non-invasive, and painless, making it a popular choice for doctors and patients alike.
Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.
Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.
The atrial septum is the wall of tissue that divides the right and left atria, which are the upper chambers of the heart. This septum ensures that oxygen-rich blood in the left atrium is kept separate from oxygen-poor blood in the right atrium. Defects or abnormalities in the atrial septum, such as a hole or a gap, can result in various heart conditions, including septal defects and congenital heart diseases.
Heart failure is a pathophysiological state in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body or do so only at the expense of elevated filling pressures. It can be caused by various cardiac disorders, including coronary artery disease, hypertension, valvular heart disease, cardiomyopathy, and arrhythmias. Symptoms may include shortness of breath, fatigue, and fluid retention. Heart failure is often classified based on the ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle during each contraction. A reduced EF (less than 40%) is indicative of heart failure with reduced ejection fraction (HFrEF), while a preserved EF (greater than or equal to 50%) is indicative of heart failure with preserved ejection fraction (HFpEF). There is also a category of heart failure with mid-range ejection fraction (HFmrEF) for those with an EF between 40-49%.
The sinoatrial (SA) node, also known as the sinus node, is the primary pacemaker of the heart. It is a small bundle of specialized cardiac conduction tissue located in the upper part of the right atrium, near the entrance of the superior vena cava. The SA node generates electrical impulses that initiate each heartbeat, causing the atria to contract and pump blood into the ventricles. This process is called sinus rhythm.
The SA node's electrical activity is regulated by the autonomic nervous system, which can adjust the heart rate in response to changes in the body's needs, such as during exercise or rest. The SA node's rate of firing determines the heart rate, with a normal resting heart rate ranging from 60 to 100 beats per minute.
If the SA node fails to function properly or its electrical impulses are blocked, other secondary pacemakers in the heart may take over, resulting in abnormal heart rhythms called arrhythmias.
The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.
Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.
Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.
The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.
Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:
1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.
Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.
Heart valve diseases are a group of conditions that affect the function of one or more of the heart's four valves (tricuspid, pulmonic, mitral, and aortic). These valves are responsible for controlling the direction and flow of blood through the heart. Heart valve diseases can cause the valves to become narrowed (stenosis), leaky (regurgitation or insufficiency), or improperly closed (prolapse), leading to disrupted blood flow within the heart and potentially causing symptoms such as shortness of breath, fatigue, chest pain, and irregular heart rhythms. The causes of heart valve diseases can include congenital defects, age-related degenerative changes, infections, rheumatic heart disease, and high blood pressure. Treatment options may include medications, surgical repair or replacement of the affected valve(s), or transcatheter procedures.
Bradycardia is a medical term that refers to an abnormally slow heart rate, typically defined as a resting heart rate of less than 60 beats per minute in adults. While some people, particularly well-trained athletes, may have a naturally low resting heart rate, bradycardia can also be a sign of an underlying health problem.
There are several potential causes of bradycardia, including:
* Damage to the heart's electrical conduction system, such as from heart disease or aging
* Certain medications, including beta blockers, calcium channel blockers, and digoxin
* Hypothyroidism (underactive thyroid gland)
* Sleep apnea
* Infection of the heart (endocarditis or myocarditis)
* Infiltrative diseases such as amyloidosis or sarcoidosis
Symptoms of bradycardia can vary depending on the severity and underlying cause. Some people with bradycardia may not experience any symptoms, while others may feel weak, fatigued, dizzy, or short of breath. In severe cases, bradycardia can lead to fainting, confusion, or even cardiac arrest.
Treatment for bradycardia depends on the underlying cause. If a medication is causing the slow heart rate, adjusting the dosage or switching to a different medication may help. In other cases, a pacemaker may be necessary to regulate the heart's rhythm. It is important to seek medical attention if you experience symptoms of bradycardia, as it can be a sign of a serious underlying condition.
An implantable defibrillator is a medical device that is surgically placed inside the chest to continuously monitor the heart's rhythm and deliver electrical shocks to restore a normal heartbeat when it detects a life-threatening arrhythmia, such as ventricular fibrillation or ventricular tachycardia.
The device consists of a small generator that is implanted in the upper chest, along with one or more electrode leads that are threaded through veins and positioned in the heart's chambers. The generator contains a battery and a microcomputer that constantly monitors the heart's electrical activity and detects any abnormal rhythms.
When an arrhythmia is detected, the defibrillator delivers an electrical shock to the heart to restore a normal rhythm. This can be done automatically by the device or manually by a healthcare provider using an external programmer.
Implantable defibrillators are typically recommended for people who have a high risk of sudden cardiac death due to a history of heart attacks, heart failure, or inherited heart conditions that affect the heart's electrical system. They can significantly reduce the risk of sudden cardiac death and improve quality of life for those at risk.
Heart disease is a broad term for a class of diseases that involve the heart or blood vessels. It's often used to refer to conditions that include:
1. Coronary artery disease (CAD): This is the most common type of heart disease. It occurs when the arteries that supply blood to the heart become hardened and narrowed due to the buildup of cholesterol and other substances, which can lead to chest pain (angina), shortness of breath, or a heart attack.
2. Heart failure: This condition occurs when the heart is unable to pump blood efficiently to meet the body's needs. It can be caused by various conditions, including coronary artery disease, high blood pressure, and cardiomyopathy.
3. Arrhythmias: These are abnormal heart rhythms, which can be too fast, too slow, or irregular. They can lead to symptoms such as palpitations, dizziness, and fainting.
4. Valvular heart disease: This involves damage to one or more of the heart's four valves, which control blood flow through the heart. Damage can be caused by various conditions, including infection, rheumatic fever, and aging.
5. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood efficiently. It can be caused by various factors, including genetics, viral infections, and drug abuse.
6. Pericardial disease: This involves inflammation or other problems with the sac surrounding the heart (pericardium). It can cause chest pain and other symptoms.
7. Congenital heart defects: These are heart conditions that are present at birth, such as a hole in the heart or abnormal blood vessels. They can range from mild to severe and may require medical intervention.
8. Heart infections: The heart can become infected by bacteria, viruses, or parasites, leading to various symptoms and complications.
It's important to note that many factors can contribute to the development of heart disease, including genetics, lifestyle choices, and certain medical conditions. Regular check-ups and a healthy lifestyle can help reduce the risk of developing heart disease.
The mitral valve, also known as the bicuspid valve, is a two-leaflet valve located between the left atrium and left ventricle in the heart. Its function is to ensure unidirectional flow of blood from the left atrium into the left ventricle during the cardiac cycle. The mitral valve consists of two leaflets (anterior and posterior), the chordae tendineae, papillary muscles, and the left atrial and ventricular myocardium. Dysfunction of the mitral valve can lead to various heart conditions such as mitral regurgitation or mitral stenosis.
Aspirin is the common name for acetylsalicylic acid, which is a medication used to relieve pain, reduce inflammation, and lower fever. It works by inhibiting the activity of an enzyme called cyclooxygenase (COX), which is involved in the production of prostaglandins, hormone-like substances that cause inflammation and pain. Aspirin also has an antiplatelet effect, which means it can help prevent blood clots from forming. This makes it useful for preventing heart attacks and strokes.
Aspirin is available over-the-counter in various forms, including tablets, capsules, and chewable tablets. It is also available in prescription strengths for certain medical conditions. As with any medication, aspirin should be taken as directed by a healthcare provider, and its use should be avoided in children and teenagers with viral infections due to the risk of Reye's syndrome, a rare but serious condition that can affect the liver and brain.
The pericardium is the double-walled sac that surrounds the heart. It has an outer fibrous layer and an inner serous layer, which further divides into two parts: the parietal layer lining the fibrous pericardium and the visceral layer (epicardium) closely adhering to the heart surface.
The space between these two layers is filled with a small amount of lubricating serous fluid, allowing for smooth movement of the heart within the pericardial cavity. The pericardium provides protection, support, and helps maintain the heart's normal position within the chest while reducing friction during heart contractions.
Procainamide is an antiarrhythmic medication used to treat various types of irregular heart rhythms (arrhythmias), such as atrial fibrillation, atrial flutter, and ventricular tachycardia. It works by prolonging the duration of the cardiac action potential and decreasing the slope of the phase 0 depolarization, which helps to stabilize the heart's electrical activity and restore a normal rhythm.
Procainamide is classified as a Class Ia antiarrhythmic drug, according to the Vaughan Williams classification system. It primarily affects the fast sodium channels in the heart muscle cells, reducing their availability during depolarization. This results in a decreased rate of impulse generation and conduction velocity, which can help to suppress abnormal rhythms.
The medication is available as an oral formulation (procainamide hydrochloride) and as an injectable solution for intravenous use. Common side effects of procainamide include nausea, vomiting, diarrhea, headache, and dizziness. Procainamide can also cause a lupus-like syndrome, characterized by joint pain, skin rashes, and other autoimmune symptoms, in some patients who take the medication for an extended period.
It is essential to monitor procainamide levels in the blood during treatment to ensure that the drug is within the therapeutic range and to minimize the risk of adverse effects. Healthcare providers should also regularly assess patients' renal function, as procainamide and its active metabolite, N-acetylprocainamide (NAPA), are primarily excreted by the kidneys.
Fibrinolytic agents are medications that dissolve or break down blood clots by activating plasminogen, which is converted into plasmin. Plasmin is a proteolytic enzyme that degrades fibrin, the structural protein in blood clots. Fibrinolytic agents are used medically to treat conditions such as acute ischemic stroke, deep vein thrombosis, pulmonary embolism, and myocardial infarction (heart attack) by restoring blood flow in occluded vessels. Examples of fibrinolytic agents include alteplase, reteplase, and tenecteplase. It is important to note that these medications carry a risk of bleeding complications and should be administered with caution.
Atrial remodeling is a term used to describe changes in the structure and function of the heart's upper chambers (the atria) that occur as a result of various cardiovascular conditions, such as heart failure, hypertension, or valvular heart disease. These changes can include enlargement of the atria, thickening of the atrial walls, and alterations in the electrical conduction system of the heart, which can lead to irregular heart rhythms (arrhythmias), such as atrial fibrillation. Atrial remodeling can also worsen existing heart conditions and increase the risk of stroke and other cardiovascular complications.
Cerebrovascular disorders are a group of medical conditions that affect the blood vessels of the brain. These disorders can be caused by narrowing, blockage, or rupture of the blood vessels, leading to decreased blood flow and oxygen supply to the brain. The most common types of cerebrovascular disorders include:
1. Stroke: A stroke occurs when a blood vessel in the brain becomes blocked or bursts, causing a lack of oxygen and nutrients to reach brain cells. This can lead to permanent damage or death of brain tissue.
2. Transient ischemic attack (TIA): Also known as a "mini-stroke," a TIA occurs when blood flow to the brain is temporarily blocked, often by a blood clot. Symptoms may last only a few minutes to a few hours and typically resolve on their own. However, a TIA is a serious warning sign that a full-blown stroke may occur in the future.
3. Aneurysm: An aneurysm is a weakened or bulging area in the wall of a blood vessel. If left untreated, an aneurysm can rupture and cause bleeding in the brain.
4. Arteriovenous malformation (AVM): An AVM is a tangled mass of abnormal blood vessels that connect arteries and veins. This can lead to bleeding in the brain or stroke.
5. Carotid stenosis: Carotid stenosis occurs when the carotid arteries, which supply blood to the brain, become narrowed or blocked due to plaque buildup. This can increase the risk of stroke.
6. Vertebrobasilar insufficiency: This condition occurs when the vertebral and basilar arteries, which supply blood to the back of the brain, become narrowed or blocked. This can lead to symptoms such as dizziness, vertigo, and difficulty swallowing.
Cerebrovascular disorders are a leading cause of disability and death worldwide. Risk factors for these conditions include age, high blood pressure, smoking, diabetes, high cholesterol, and family history. Treatment may involve medications, surgery, or lifestyle changes to reduce the risk of further complications.
Electrophysiology is a branch of medicine that deals with the electrical activities of the body, particularly the heart. In a medical context, electrophysiology studies (EPS) are performed to assess abnormal heart rhythms (arrhythmias) and to evaluate the effectiveness of certain treatments, such as medication or pacemakers.
During an EPS, electrode catheters are inserted into the heart through blood vessels in the groin or neck. These catheters can record the electrical activity of the heart and stimulate it to help identify the source of the arrhythmia. The information gathered during the study can help doctors determine the best course of treatment for each patient.
In addition to cardiac electrophysiology, there are also other subspecialties within electrophysiology, such as neuromuscular electrophysiology, which deals with the electrical activity of the nervous system and muscles.
Pyridones are a class of organic compounds that contain a pyridone ring, which is a heterocyclic ring consisting of a six-membered ring with five carbon atoms and one nitrogen atom, with one oxygen atom attached to the nitrogen atom by a double bond. Pyridones can be found in various natural sources, including plants and microorganisms, and they also have important applications in the pharmaceutical industry as building blocks for drug design and synthesis. Some drugs that contain pyridone rings include antihistamines, anti-inflammatory agents, and antiviral agents.
Benzimidazoles are a class of heterocyclic compounds containing a benzene fused to a imidazole ring. They have a wide range of pharmacological activities and are used in the treatment of various diseases. Some of the benzimidazoles are used as antiparasitics, such as albendazole and mebendazole, which are effective against a variety of worm infestations. Other benzimidazoles have antifungal properties, such as thiabendazole and fuberidazole, and are used to treat fungal infections. Additionally, some benzimidazoles have been found to have anti-cancer properties and are being investigated for their potential use in cancer therapy.
Heart block is a cardiac condition characterized by the interruption of electrical impulse transmission from the atria (the upper chambers of the heart) to the ventricles (the lower chambers of the heart). This disruption can lead to abnormal heart rhythms, including bradycardia (a slower-than-normal heart rate), and in severe cases, can cause the heart to stop beating altogether. Heart block is typically caused by damage to the heart's electrical conduction system due to various factors such as aging, heart disease, or certain medications.
There are three types of heart block: first-degree, second-degree, and third-degree (also known as complete heart block). Each type has distinct electrocardiogram (ECG) findings and symptoms. Treatment for heart block depends on the severity of the condition and may include monitoring, medication, or implantation of a pacemaker to regulate the heart's electrical activity.
Ventricular Tachycardia (VT) is a rapid heart rhythm that originates from the ventricles, the lower chambers of the heart. It is defined as three or more consecutive ventricular beats at a rate of 120 beats per minute or greater in a resting adult. This abnormal heart rhythm can cause the heart to pump less effectively, leading to inadequate blood flow to the body and potentially life-threatening conditions such as hypotension, shock, or cardiac arrest.
VT can be classified into three types based on its duration, hemodynamic stability, and response to treatment:
1. Non-sustained VT (NSVT): It lasts for less than 30 seconds and is usually well tolerated without causing significant symptoms or hemodynamic instability.
2. Sustained VT (SVT): It lasts for more than 30 seconds, causes symptoms such as palpitations, dizziness, shortness of breath, or chest pain, and may lead to hemodynamic instability.
3. Pulseless VT: It is a type of sustained VT that does not produce a pulse, blood pressure, or adequate cardiac output, requiring immediate electrical cardioversion or defibrillation to restore a normal heart rhythm.
VT can occur in people with various underlying heart conditions such as coronary artery disease, cardiomyopathy, valvular heart disease, congenital heart defects, and electrolyte imbalances. It can also be triggered by certain medications, substance abuse, or electrical abnormalities in the heart. Prompt diagnosis and treatment of VT are crucial to prevent complications and improve outcomes.
Disopyramide is an antiarrhythmic medication that is primarily used to treat certain types of irregular heart rhythms (arrhythmias), such as ventricular tachycardia and atrial fibrillation. It works by blocking the activity of sodium channels in the heart, which helps to slow down and regulate the heart rate.
Disopyramide is available in immediate-release and extended-release forms, and it may be taken orally as a tablet or capsule. Common side effects of this medication include dry mouth, blurred vision, constipation, and difficulty urinating. More serious side effects can include dizziness, fainting, irregular heartbeat, and allergic reactions.
It is important to take disopyramide exactly as directed by a healthcare provider, as improper use or dosing can lead to serious complications. Additionally, individuals with certain medical conditions, such as heart failure, kidney disease, or myasthenia gravis, may not be able to safely take this medication.
Cardiovascular models are simplified representations or simulations of the human cardiovascular system used in medical research, education, and training. These models can be physical, computational, or mathematical and are designed to replicate various aspects of the heart, blood vessels, and blood flow. They can help researchers study the structure and function of the cardiovascular system, test new treatments and interventions, and train healthcare professionals in diagnostic and therapeutic techniques.
Physical cardiovascular models may include artificial hearts, blood vessels, or circulation systems made from materials such as plastic, rubber, or silicone. These models can be used to study the mechanics of heart valves, the effects of different surgical procedures, or the impact of various medical devices on blood flow.
Computational and mathematical cardiovascular models use algorithms and equations to simulate the behavior of the cardiovascular system. These models may range from simple representations of a single heart chamber to complex simulations of the entire circulatory system. They can be used to study the electrical activity of the heart, the biomechanics of blood flow, or the distribution of drugs in the body.
Overall, cardiovascular models play an essential role in advancing our understanding of the human body and improving patient care.
The Chi-square distribution is a continuous probability distribution that is often used in statistical hypothesis testing. It is the distribution of a sum of squares of k independent standard normal random variables. The resulting quantity follows a chi-square distribution with k degrees of freedom, denoted as χ²(k).
The probability density function (pdf) of the Chi-square distribution with k degrees of freedom is given by:
f(x; k) = (1/ (2^(k/2) * Γ(k/2))) \* x^((k/2)-1) \* e^(-x/2), for x > 0 and 0, otherwise.
Where Γ(k/2) is the gamma function evaluated at k/2. The mean and variance of a Chi-square distribution with k degrees of freedom are k and 2k, respectively.
The Chi-square distribution has various applications in statistical inference, including testing goodness-of-fit, homogeneity of variances, and independence in contingency tables.
Adrenergic beta-antagonists, also known as beta blockers, are a class of medications that block the effects of adrenaline and noradrenaline (also known as epinephrine and norepinephrine) on beta-adrenergic receptors. These receptors are found in various tissues throughout the body, including the heart, lungs, and blood vessels.
Beta blockers work by binding to these receptors and preventing the activation of certain signaling pathways that lead to increased heart rate, force of heart contractions, and relaxation of blood vessels. As a result, beta blockers can lower blood pressure, reduce heart rate, and decrease the workload on the heart.
Beta blockers are used to treat a variety of medical conditions, including hypertension (high blood pressure), angina (chest pain), heart failure, irregular heart rhythms, migraines, and certain anxiety disorders. Some common examples of beta blockers include metoprolol, atenolol, propranolol, and bisoprolol.
It is important to note that while beta blockers can have many benefits, they can also cause side effects such as fatigue, dizziness, and shortness of breath. Additionally, sudden discontinuation of beta blocker therapy can lead to rebound hypertension or worsening chest pain. Therefore, it is important to follow the dosing instructions provided by a healthcare provider carefully when taking these medications.
Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.
An action potential is a brief electrical signal that travels along the membrane of a nerve cell (neuron) or muscle cell. It is initiated by a rapid, localized change in the permeability of the cell membrane to specific ions, such as sodium and potassium, resulting in a rapid influx of sodium ions and a subsequent efflux of potassium ions. This ion movement causes a brief reversal of the electrical potential across the membrane, which is known as depolarization. The action potential then propagates along the cell membrane as a wave, allowing the electrical signal to be transmitted over long distances within the body. Action potentials play a crucial role in the communication and functioning of the nervous system and muscle tissue.
Multivariate analysis is a statistical method used to examine the relationship between multiple independent variables and a dependent variable. It allows for the simultaneous examination of the effects of two or more independent variables on an outcome, while controlling for the effects of other variables in the model. This technique can be used to identify patterns, associations, and interactions among multiple variables, and is commonly used in medical research to understand complex health outcomes and disease processes. Examples of multivariate analysis methods include multiple regression, factor analysis, cluster analysis, and discriminant analysis.
Aprindine is a class IA antiarrhythmic agent, which is primarily used to treat cardiac arrhythmias (abnormal heart rhythms). It works by blocking sodium channels in the heart muscle cells, which helps to stabilize the heart's electrical activity and restore normal rhythm.
The medical definition of Aprindine can be stated as:
"Aprindine is a sodium channel blocker that is used in the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia. It works by slowing down the conduction of electrical impulses through the heart muscle cells, which helps to restore normal rhythm."
It is important to note that Aprindine can have serious side effects, including increased risk of ventricular arrhythmias and cardiac arrest, especially when used in high doses or in patients with certain underlying medical conditions. Therefore, it should only be prescribed by a healthcare professional who has experience in managing cardiac arrhythmias.
Mitral valve stenosis is a cardiac condition characterized by the narrowing or stiffening of the mitral valve, one of the four heart valves that regulate blood flow through the heart. This narrowing prevents the mitral valve from fully opening during diastole (relaxation phase of the heart cycle), leading to restricted flow of oxygenated blood from the left atrium into the left ventricle.
The narrowing or stiffening of the mitral valve can be caused by various factors, such as rheumatic heart disease, congenital heart defects, aging, or calcium deposits on the valve leaflets. As a result, the left atrium has to work harder to pump blood into the left ventricle, causing increased pressure in the left atrium and pulmonary veins. This can lead to symptoms such as shortness of breath, fatigue, coughing, and heart palpitations.
Mitral valve stenosis is typically diagnosed through a combination of medical history, physical examination, and imaging techniques like echocardiography or cardiac catheterization. Treatment options may include medications to manage symptoms and prevent complications, as well as surgical interventions such as mitral valve repair or replacement to alleviate the stenosis and improve heart function.
Coronary artery bypass surgery, also known as coronary artery bypass grafting (CABG), is a surgical procedure used to improve blood flow to the heart in patients with severe coronary artery disease. This condition occurs when the coronary arteries, which supply oxygen-rich blood to the heart muscle, become narrowed or blocked due to the buildup of fatty deposits, called plaques.
During CABG surgery, a healthy blood vessel from another part of the body is grafted, or attached, to the coronary artery, creating a new pathway for oxygen-rich blood to flow around the blocked or narrowed portion of the artery and reach the heart muscle. This bypass helps to restore normal blood flow and reduce the risk of angina (chest pain), shortness of breath, and other symptoms associated with coronary artery disease.
There are different types of CABG surgery, including traditional on-pump CABG, off-pump CABG, and minimally invasive CABG. The choice of procedure depends on various factors, such as the patient's overall health, the number and location of blocked arteries, and the presence of other medical conditions.
It is important to note that while CABG surgery can significantly improve symptoms and quality of life in patients with severe coronary artery disease, it does not cure the underlying condition. Lifestyle modifications, such as regular exercise, a healthy diet, smoking cessation, and medication therapy, are essential for long-term management and prevention of further progression of the disease.
Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.
Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.
Autonomic denervation is a medical term that refers to the interruption or loss of nerve supply to the autonomic nervous system. The autonomic nervous system is the part of the nervous system that controls involuntary actions, such as heart rate, blood pressure, digestion, and pupil dilation.
Autonomic denervation can occur due to various reasons, including surgical procedures, trauma, degenerative diseases, or medical conditions such as diabetes. The interruption of nerve supply can lead to a range of symptoms depending on the specific autonomic functions that are affected.
For example, autonomic denervation in the heart can lead to abnormal heart rhythms or low blood pressure. In the digestive system, it can cause problems with motility and secretion, leading to symptoms such as bloating, constipation, or diarrhea. Autonomic denervation in the eyes can result in pupil abnormalities, dry eyes, or light sensitivity.
Treatment for autonomic denervation depends on the underlying cause and the specific symptoms that are present. In some cases, medication may be used to manage symptoms, while in others, surgical intervention may be necessary to repair or restore nerve function.
A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.
Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.
Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.
Vitamin K is a fat-soluble vitamin that plays a crucial role in blood clotting and bone metabolism. It is essential for the production of several proteins involved in blood clotting, including factor II (prothrombin), factor VII, factor IX, and factor X. Additionally, Vitamin K is necessary for the synthesis of osteocalcin, a protein that contributes to bone health by regulating the deposition of calcium in bones.
There are two main forms of Vitamin K: Vitamin K1 (phylloquinone), which is found primarily in green leafy vegetables and some vegetable oils, and Vitamin K2 (menaquinones), which is produced by bacteria in the intestines and is also found in some fermented foods.
Vitamin K deficiency can lead to bleeding disorders such as hemorrhage and excessive bruising. While Vitamin K deficiency is rare in adults, it can occur in newborns who have not yet developed sufficient levels of the vitamin. Therefore, newborns are often given a Vitamin K injection shortly after birth to prevent bleeding problems.
"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:
1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.
Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.
Premature cardiac complexes, also known as premature heartbeats or premature ventricular contractions (PVCs), refer to extra or early heartbeats that originate in the lower chambers of the heart (the ventricles). These extra beats disrupt the normal rhythm and sequence of heartbeats, causing the heart to beat earlier than expected.
Premature cardiac complexes can occur in healthy individuals as well as those with heart disease. They are usually harmless and do not cause any symptoms, but in some cases, they may cause palpitations, skipped beats, or a fluttering sensation in the chest. In rare cases, frequent premature cardiac complexes can lead to more serious heart rhythm disorders or decreased heart function.
The diagnosis of premature cardiac complexes is usually made through an electrocardiogram (ECG) or Holter monitoring, which records the electrical activity of the heart over a period of time. Treatment is typically not necessary unless the premature complexes are frequent, symptomatic, or associated with underlying heart disease. In such cases, medications, cardioversion, or catheter ablation may be recommended.
Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.
Rheumatic Heart Disease (RHD) is defined as a chronic heart condition caused by damage to the heart valves due to untreated or inadequately treated streptococcal throat infection (strep throat). The immune system's response to this infection can mistakenly attack and damage the heart tissue, leading to inflammation and scarring of the heart valves. This damage can result in narrowing, leakage, or abnormal functioning of the heart valves, which can further lead to complications such as heart failure, stroke, or infective endocarditis.
RHD is a preventable and treatable condition if detected early and managed effectively. It primarily affects children and young adults in developing countries where access to healthcare and antibiotics for strep throat infections may be limited. Long-term management of RHD typically involves medications, regular monitoring, and sometimes surgical intervention to repair or replace damaged heart valves.
Pulmonary Veno-Occlusive Disease (PVOD) is a rare form of pulmonary hypertension, characterized by the obstruction or blockage of the pulmonary veins. This obstruction can lead to increased pressure in the pulmonary circulation, ultimately causing right heart failure.
The medical definition of Pulmonary Veno-Occlusive Disease is: "A progressive and often fatal condition in which there is a selective occlusion or obliteration of the pulmonary venules and small veins, resulting in pulmonary hypertension, right ventricular failure, and death."
The obstruction of the pulmonary veins can be caused by various factors, including inflammation, fibrosis, or thrombosis. Symptoms of PVOD may include shortness of breath, fatigue, coughing up blood, and signs of right heart failure such as peripheral edema and ascites.
Diagnosis of PVOD can be challenging due to its rarity and nonspecific symptoms. Imaging studies, such as chest X-ray or CT scan, may show signs of pulmonary congestion and enlarged central pulmonary veins. A definitive diagnosis usually requires a lung biopsy.
Treatment options for PVOD are limited, and there is no cure for the disease. Currently, lung transplantation remains the only potentially curative treatment option for patients with PVOD.
Stroke volume is a term used in cardiovascular physiology and medicine. It refers to the amount of blood that is pumped out of the left ventricle of the heart during each contraction (systole). Specifically, it is the difference between the volume of blood in the left ventricle at the end of diastole (when the ventricle is filled with blood) and the volume at the end of systole (when the ventricle has contracted and ejected its contents into the aorta).
Stroke volume is an important measure of heart function, as it reflects the ability of the heart to pump blood effectively to the rest of the body. A low stroke volume may indicate that the heart is not pumping efficiently, while a high stroke volume may suggest that the heart is working too hard. Stroke volume can be affected by various factors, including heart disease, high blood pressure, and physical fitness level.
The formula for calculating stroke volume is:
Stroke Volume = End-Diastolic Volume - End-Systolic Volume
Where end-diastolic volume (EDV) is the volume of blood in the left ventricle at the end of diastole, and end-systolic volume (ESV) is the volume of blood in the left ventricle at the end of systole.
The coronary sinus is a large vein that receives blood from the heart's muscle tissue. It is located on the posterior side of the heart and is a part of the cardiovascular system. The coronary sinus collects oxygen-depleted blood from the myocardium (the heart muscle) and drains it into the right atrium, where it will then be pumped to the lungs for oxygenation.
The coronary sinus is an essential structure in medical procedures such as cardiac catheterization and electrophysiological studies. It is also a common site for the implantation of pacemakers and other cardiac devices.
Cardiac arrest, also known as heart arrest, is a medical condition where the heart suddenly stops beating or functioning properly. This results in the cessation of blood flow to the rest of the body, including the brain, leading to loss of consciousness and pulse. Cardiac arrest is often caused by electrical disturbances in the heart that disrupt its normal rhythm, known as arrhythmias. If not treated immediately with cardiopulmonary resuscitation (CPR) and defibrillation, it can lead to death or permanent brain damage due to lack of oxygen supply. It's important to note that a heart attack is different from cardiac arrest; a heart attack occurs when blood flow to a part of the heart is blocked, often by a clot, causing damage to the heart muscle, but the heart continues to beat. However, a heart attack can sometimes trigger a cardiac arrest.
Proportional hazards models are a type of statistical analysis used in medical research to investigate the relationship between covariates (predictor variables) and survival times. The most common application of proportional hazards models is in the Cox regression model, which is named after its developer, Sir David Cox.
In a proportional hazards model, the hazard rate or risk of an event occurring at a given time is assumed to be proportional to the hazard rate of a reference group, after adjusting for the covariates. This means that the ratio of the hazard rates between any two individuals remains constant over time, regardless of their survival times.
Mathematically, the hazard function h(t) at time t for an individual with a set of covariates X can be expressed as:
h(t|X) = h0(t) \* exp(β1X1 + β2X2 + ... + βpXp)
where h0(t) is the baseline hazard function, X1, X2, ..., Xp are the covariates, and β1, β2, ..., βp are the regression coefficients that represent the effect of each covariate on the hazard rate.
The assumption of proportionality is crucial in the interpretation of the results from a Cox regression model. If the assumption is violated, then the estimated regression coefficients may be biased and misleading. Therefore, it is important to test for the proportional hazards assumption before interpreting the results of a Cox regression analysis.
Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel, obstructing the flow of blood through the circulatory system. When a clot forms in an artery, it can cut off the supply of oxygen and nutrients to the tissues served by that artery, leading to damage or tissue death. If a thrombus forms in the heart, it can cause a heart attack. If a thrombus breaks off and travels through the bloodstream, it can lodge in a smaller vessel, causing blockage and potentially leading to damage in the organ that the vessel supplies. This is known as an embolism.
Thrombosis can occur due to various factors such as injury to the blood vessel wall, abnormalities in blood flow, or changes in the composition of the blood. Certain medical conditions, medications, and lifestyle factors can increase the risk of thrombosis. Treatment typically involves anticoagulant or thrombolytic therapy to dissolve or prevent further growth of the clot, as well as addressing any underlying causes.
An esophageal fistula is an abnormal connection or passage between the esophagus (the tube that carries food and liquids from the throat to the stomach) and another organ, such as the trachea (windpipe) or the skin. This condition can result from complications of certain medical conditions, including cancer, prolonged infection, or injury to the esophagus.
Esophageal fistulas can cause a variety of symptoms, including difficulty swallowing, coughing, chest pain, and fever. They can also lead to serious complications, such as pneumonia or sepsis, if left untreated. Treatment for an esophageal fistula typically involves surgical repair of the abnormal connection, along with management of any underlying conditions that may have contributed to its development.
Left ventricular dysfunction (LVD) is a condition characterized by the impaired ability of the left ventricle of the heart to pump blood efficiently during contraction. The left ventricle is one of the four chambers of the heart and is responsible for pumping oxygenated blood to the rest of the body.
LVD can be caused by various underlying conditions, such as coronary artery disease, cardiomyopathy, valvular heart disease, or hypertension. These conditions can lead to structural changes in the left ventricle, including remodeling, hypertrophy, and dilation, which ultimately impair its contractile function.
The severity of LVD is often assessed by measuring the ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle during each contraction. A normal EF ranges from 55% to 70%, while an EF below 40% is indicative of LVD.
LVD can lead to various symptoms, such as shortness of breath, fatigue, fluid retention, and decreased exercise tolerance. It can also increase the risk of complications, such as heart failure, arrhythmias, and cardiac arrest. Treatment for LVD typically involves managing the underlying cause, along with medications to improve contractility, reduce fluid buildup, and control heart rate. In severe cases, devices such as implantable cardioverter-defibrillators (ICDs) or left ventricular assist devices (LVADs) may be required.
The heart ventricles are the two lower chambers of the heart that receive blood from the atria and pump it to the lungs or the rest of the body. The right ventricle pumps deoxygenated blood to the lungs, while the left ventricle pumps oxygenated blood to the rest of the body. Both ventricles have thick, muscular walls to generate the pressure necessary to pump blood through the circulatory system.
Computer-assisted signal processing is a medical term that refers to the use of computer algorithms and software to analyze, interpret, and extract meaningful information from biological signals. These signals can include physiological data such as electrocardiogram (ECG) waves, electromyography (EMG) signals, electroencephalography (EEG) readings, or medical images.
The goal of computer-assisted signal processing is to automate the analysis of these complex signals and extract relevant features that can be used for diagnostic, monitoring, or therapeutic purposes. This process typically involves several steps, including:
1. Signal acquisition: Collecting raw data from sensors or medical devices.
2. Preprocessing: Cleaning and filtering the data to remove noise and artifacts.
3. Feature extraction: Identifying and quantifying relevant features in the signal, such as peaks, troughs, or patterns.
4. Analysis: Applying statistical or machine learning algorithms to interpret the extracted features and make predictions about the underlying physiological state.
5. Visualization: Presenting the results in a clear and intuitive way for clinicians to review and use.
Computer-assisted signal processing has numerous applications in healthcare, including:
* Diagnosing and monitoring cardiac arrhythmias or other heart conditions using ECG signals.
* Assessing muscle activity and function using EMG signals.
* Monitoring brain activity and diagnosing neurological disorders using EEG readings.
* Analyzing medical images to detect abnormalities, such as tumors or fractures.
Overall, computer-assisted signal processing is a powerful tool for improving the accuracy and efficiency of medical diagnosis and monitoring, enabling clinicians to make more informed decisions about patient care.
The Kaplan-Meier estimate is a statistical method used to calculate the survival probability over time in a population. It is commonly used in medical research to analyze time-to-event data, such as the time until a patient experiences a specific event like disease progression or death. The Kaplan-Meier estimate takes into account censored data, which occurs when some individuals are lost to follow-up before experiencing the event of interest.
The method involves constructing a survival curve that shows the proportion of subjects still surviving at different time points. At each time point, the survival probability is calculated as the product of the conditional probabilities of surviving from one time point to the next. The Kaplan-Meier estimate provides an unbiased and consistent estimator of the survival function, even when censoring is present.
In summary, the Kaplan-Meier estimate is a crucial tool in medical research for analyzing time-to-event data and estimating survival probabilities over time while accounting for censored observations.
Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.
Platelet aggregation inhibitors are a class of medications that prevent platelets (small blood cells involved in clotting) from sticking together and forming a clot. These drugs work by interfering with the ability of platelets to adhere to each other and to the damaged vessel wall, thereby reducing the risk of thrombosis (blood clot formation).
Platelet aggregation inhibitors are often prescribed for people who have an increased risk of developing blood clots due to various medical conditions such as atrial fibrillation, coronary artery disease, peripheral artery disease, stroke, or a history of heart attack. They may also be used in patients undergoing certain medical procedures, such as angioplasty and stenting, to prevent blood clot formation in the stents.
Examples of platelet aggregation inhibitors include:
1. Aspirin: A nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits the enzyme cyclooxygenase, which is involved in platelet activation and aggregation.
2. Clopidogrel (Plavix): A P2Y12 receptor antagonist that selectively blocks ADP-induced platelet activation and aggregation.
3. Prasugrel (Effient): A third-generation thienopyridine P2Y12 receptor antagonist, similar to clopidogrel but with faster onset and greater potency.
4. Ticagrelor (Brilinta): A direct-acting P2Y12 receptor antagonist that does not require metabolic activation and has a reversible binding profile.
5. Dipyridamole (Persantine): An antiplatelet agent that inhibits platelet aggregation by increasing cyclic adenosine monophosphate (cAMP) levels in platelets, which leads to decreased platelet reactivity.
6. Iloprost (Ventavis): A prostacyclin analogue that inhibits platelet aggregation and causes vasodilation, often used in the treatment of pulmonary arterial hypertension.
7. Cilostazol (Pletal): A phosphodiesterase III inhibitor that increases cAMP levels in platelets, leading to decreased platelet activation and aggregation, as well as vasodilation.
8. Ticlopidine (Ticlid): An older P2Y12 receptor antagonist with a slower onset of action and more frequent side effects compared to clopidogrel or prasugrel.
Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.
In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.
Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.
Epicardial mapping is a medical procedure used to create a detailed map of the electrical activity on the surface of the heart (epicardium). This technique is often used during electrophysiology studies to help diagnose and locate the source of abnormal heart rhythms, such as ventricular tachycardia or atrial fibrillation.
During epicardial mapping, a specialist (usually an electrophysiologist) will introduce a catheter through a vein or artery, which is then guided to the heart. Once in position, electrodes on the tip of the catheter record electrical signals from the heart's surface. These signals are used to create a detailed map of the heart's electrical activity, allowing the specialist to identify areas with abnormal electrical patterns.
This information can be crucial for determining the best course of treatment, such as targeted ablation therapy to eliminate the source of the arrhythmia. Epicardial mapping is typically performed in an electrophysiology lab or cardiac catheterization laboratory under fluoroscopy guidance, and it requires expertise in both cardiovascular medicine and interventional techniques.
The superior vena cava is a large vein that carries deoxygenated blood from the upper half of the body to the right atrium of the heart. It is formed by the union of the left and right brachiocephalic veins (also known as the internal jugular and subclavian veins) near the base of the neck. The superior vena cava runs posteriorly to the sternum and enters the upper right portion of the right atrium, just posterior to the opening of the inferior vena cava. It plays a crucial role in the circulatory system by allowing blood returning from the head, neck, upper limbs, and thorax to bypass the liver before entering the heart.
A cardiac catheter is a thin, flexible tube that is inserted into the heart or adjacent blood vessels during a cardiac catheterization procedure. This procedure is typically performed to diagnose and treat various cardiovascular conditions such as heart disease, heart defects, or abnormal heart rhythms.
Cardiac catheters can be used for several purposes:
1. To measure the pressure and oxygen levels in different chambers of the heart and blood vessels.
2. To inject dye into the coronary arteries to visualize blockages or narrowing through angiography.
3. To perform interventions such as balloon angioplasty, stent placement, or valvuloplasty to open up blocked or narrowed blood vessels or repair damaged heart valves.
4. To collect samples of heart muscle tissue for biopsy, which can help diagnose conditions like cardiomyopathy or myocarditis.
There are various types of cardiac catheters, including:
1. Diagnostic catheters - used to measure pressure and oxygen levels in the heart and blood vessels.
2. Guiding catheters - used to guide other interventional devices like balloons or stents into place.
3. Angioplasty balloon catheters - used to inflate a balloon at the tip of the catheter, which helps open up blocked or narrowed blood vessels.
4. Thermodilution catheters - used to measure cardiac output and other hemodynamic parameters.
5. Microcatheters - smaller, more flexible catheters used for complex interventions or accessing difficult-to-reach areas of the heart and blood vessels.
Cardiac catheterization is a minimally invasive procedure that usually requires only local anesthesia and mild sedation. The recovery time is typically short, with most patients returning home within 24 hours after the procedure.
Pericarditis is a medical condition characterized by inflammation of the pericardium, which is the thin sac-like membrane that surrounds the heart and contains serous fluid to reduce friction during heartbeats. The inflammation can cause symptoms such as chest pain, shortness of breath, and sometimes fever.
The pericardium has two layers: the visceral pericardium, which is tightly adhered to the heart's surface, and the parietal pericardium, which lines the inner surface of the chest cavity. Normally, there is a small amount of fluid between these two layers, allowing for smooth movement of the heart within the chest cavity.
In pericarditis, the inflammation causes the pericardial layers to become irritated and swollen, leading to an accumulation of excess fluid in the pericardial space. This can result in a condition called pericardial effusion, which can further complicate the situation by putting pressure on the heart and impairing its function.
Pericarditis may be caused by various factors, including viral or bacterial infections, autoimmune disorders, heart attacks, trauma, or cancer. Treatment typically involves addressing the underlying cause, managing symptoms, and reducing inflammation with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. In severe cases, pericardiocentesis (removal of excess fluid from the pericardial space) or surgical intervention may be necessary.
A randomized controlled trial (RCT) is a type of clinical study in which participants are randomly assigned to receive either the experimental intervention or the control condition, which may be a standard of care, placebo, or no treatment. The goal of an RCT is to minimize bias and ensure that the results are due to the intervention being tested rather than other factors. This design allows for a comparison between the two groups to determine if there is a significant difference in outcomes. RCTs are often considered the gold standard for evaluating the safety and efficacy of medical interventions, as they provide a high level of evidence for causal relationships between the intervention and health outcomes.
Atrioventricular (AV) block is a disorder of the electrical conduction system of the heart that causes a delay or interruption in the transmission of electrical signals from the atria (the upper chambers of the heart) to the ventricles (the lower chambers of the heart). This results in an abnormal heart rhythm, also known as an arrhythmia.
There are three degrees of AV block:
1. First-degree AV block: In this type of AV block, there is a delay in the conduction of electrical signals from the atria to the ventricles, but all signals are eventually conducted. This condition may not cause any symptoms and is often discovered during a routine electrocardiogram (ECG).
2. Second-degree AV block: In this type of AV block, some electrical signals from the atria are not conducted to the ventricles. There are two types of second-degree AV block: Mobitz type I and Mobitz type II. Mobitz type I is characterized by a progressive prolongation of the PR interval (the time between the electrical activation of the atria and ventricles) until a QRS complex (which represents the electrical activation of the ventricles) is dropped. Mobitz type II is characterized by a constant PR interval with occasional non-conducted P waves.
3. Third-degree AV block: In this type of AV block, no electrical signals are conducted from the atria to the ventricles. The atria and ventricles beat independently of each other, resulting in a slow heart rate (bradycardia) and an irregular rhythm. This condition can be life-threatening if not treated promptly.
The causes of AV block include aging, heart disease, medications, and certain medical conditions such as hypothyroidism and Lyme disease. Treatment depends on the severity of the condition and may include medication, a pacemaker, or surgery.
The endocardium is the innermost layer of tissue that lines the chambers of the heart and the valves between them. It is a thin, smooth membrane that is in contact with the blood within the heart. This layer helps to maintain the heart's internal environment, facilitates the smooth movement of blood through the heart, and provides a protective barrier against infection and other harmful substances. The endocardium is composed of simple squamous epithelial cells called endothelial cells, which are supported by a thin layer of connective tissue.
Quinidine is a Class IA antiarrhythmic medication that is primarily used to treat and prevent various types of cardiac arrhythmias (abnormal heart rhythms). It works by blocking the rapid sodium channels in the heart, which helps to slow down the conduction of electrical signals within the heart and stabilize its rhythm.
Quinidine is derived from the bark of the Cinchona tree and has been used for centuries as a treatment for malaria. However, its antiarrhythmic properties were discovered later, and it became an important medication in cardiology.
In addition to its use in treating arrhythmias, quinidine may also be used off-label for other indications such as the treatment of nocturnal leg cramps or myasthenia gravis. It is available in various forms, including tablets and injectable solutions.
It's important to note that quinidine has a narrow therapeutic index, meaning that there is only a small difference between an effective dose and a toxic one. Therefore, it must be carefully monitored to ensure that the patient is receiving a safe and effective dose. Common side effects of quinidine include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as visual disturbances, headache, and dizziness. More serious side effects can include QT prolongation, which can lead to dangerous arrhythmias, and hypersensitivity reactions.
Fluoroscopy is a type of medical imaging that uses X-rays to obtain real-time moving images of the internal structures of the body. A continuous X-ray beam is passed through the body part being examined, and the resulting fluoroscopic images are transmitted to a monitor, allowing the medical professional to view the structure and movement of the internal organs and bones in real time.
Fluoroscopy is often used to guide minimally invasive procedures such as catheterization, stent placement, or joint injections. It can also be used to diagnose and monitor a variety of medical conditions, including gastrointestinal disorders, musculoskeletal injuries, and cardiovascular diseases.
It is important to note that fluoroscopy involves exposure to ionizing radiation, and the risks associated with this exposure should be carefully weighed against the benefits of the procedure. Medical professionals are trained to use the lowest possible dose of radiation necessary to obtain the desired diagnostic information.
Digitalis glycosides are a type of cardiac glycoside that are derived from the foxglove plant (Digitalis purpurea) and related species. These compounds have a steroidal structure with a lactone ring attached to the molecule, which is responsible for their positive inotropic effects on the heart.
The two main digitalis glycosides used clinically are digoxin and digitoxin. They work by inhibiting the sodium-potassium pump in cardiac muscle cells, leading to an increase in intracellular calcium levels and a subsequent enhancement of myocardial contractility. This makes them useful in the treatment of heart failure and atrial arrhythmias such as atrial fibrillation.
However, digitalis glycosides have a narrow therapeutic index, meaning that there is only a small difference between their therapeutic and toxic doses. Therefore, they must be administered with caution and patients should be closely monitored for signs of toxicity such as nausea, vomiting, visual disturbances, and cardiac arrhythmias.
A feasibility study is a preliminary investigation or analysis conducted to determine the viability of a proposed project, program, or product. In the medical field, feasibility studies are often conducted before implementing new treatments, procedures, equipment, or facilities. These studies help to assess the practicality and effectiveness of the proposed intervention, as well as its potential benefits and risks.
Feasibility studies in healthcare typically involve several steps:
1. Problem identification: Clearly define the problem that the proposed project, program, or product aims to address.
2. Objectives setting: Establish specific, measurable, achievable, relevant, and time-bound (SMART) objectives for the study.
3. Literature review: Conduct a thorough review of existing research and best practices related to the proposed intervention.
4. Methodology development: Design a methodology for data collection and analysis that will help answer the research questions and achieve the study's objectives.
5. Resource assessment: Evaluate the availability and adequacy of resources, including personnel, time, and finances, required to carry out the proposed intervention.
6. Risk assessment: Identify potential risks and challenges associated with the implementation of the proposed intervention and develop strategies to mitigate them.
7. Cost-benefit analysis: Estimate the costs and benefits of the proposed intervention, including direct and indirect costs, as well as short-term and long-term benefits.
8. Stakeholder engagement: Engage relevant stakeholders, such as patients, healthcare providers, administrators, and policymakers, to gather their input and support for the proposed intervention.
9. Decision-making: Based on the findings of the feasibility study, make an informed decision about whether or not to proceed with the proposed project, program, or product.
Feasibility studies are essential in healthcare as they help ensure that resources are allocated efficiently and effectively, and that interventions are evidence-based, safe, and beneficial for patients.
Doppler echocardiography is a type of ultrasound test that uses high-frequency sound waves to produce detailed images of the heart and its blood vessels. It measures the direction and speed of blood flow in the heart and major blood vessels leading to and from the heart. This helps to evaluate various conditions such as valve problems, congenital heart defects, and heart muscle diseases.
In Doppler echocardiography, a small handheld device called a transducer is placed on the chest, which emits sound waves that bounce off the heart and blood vessels. The transducer then picks up the returning echoes, which are processed by a computer to create moving images of the heart.
The Doppler effect is used to measure the speed and direction of blood flow. This occurs when the frequency of the sound waves changes as they bounce off moving objects, such as red blood cells. By analyzing these changes, the ultrasound machine can calculate the velocity and direction of blood flow in different parts of the heart.
Doppler echocardiography is a non-invasive test that does not require any needles or dyes. It is generally safe and painless, although patients may experience some discomfort from the pressure applied by the transducer on the chest. The test usually takes about 30 to 60 minutes to complete.
Ablation techniques are medical procedures that involve the removal or destruction of body tissue or cells. This can be done through various methods, including:
1. Radiofrequency ablation (RFA): This technique uses heat generated by radio waves to destroy targeted tissue. A thin probe is inserted into the body, and the tip of the probe emits high-frequency electrical currents that heat up and destroy the surrounding tissue.
2. Cryoablation: Also known as cryosurgery, this technique uses extreme cold to destroy abnormal tissue. A probe is inserted into the body, and a gas is passed through it to create a ball of ice that freezes and destroys the targeted tissue.
3. Microwave ablation: This technique uses microwaves to heat up and destroy targeted tissue. A probe is inserted into the body, and microwaves are emitted from the tip of the probe to heat up and destroy the surrounding tissue.
4. Laser ablation: This technique uses laser energy to vaporize and destroy targeted tissue. A laser fiber is inserted into the body, and the laser energy is directed at the targeted tissue to destroy it.
5. High-intensity focused ultrasound (HIFU): This technique uses high-frequency sound waves to heat up and destroy targeted tissue. The sound waves are focused on a specific area of the body, and the heat generated by the sound waves destroys the targeted tissue.
Ablation techniques are used in various medical fields, including cardiology, oncology, and neurology, to treat a range of conditions such as arrhythmias, cancer, and chronic pain.
Brain ischemia is the medical term used to describe a reduction or interruption of blood flow to the brain, leading to a lack of oxygen and glucose delivery to brain tissue. This can result in brain damage or death of brain cells, known as infarction. Brain ischemia can be caused by various conditions such as thrombosis (blood clot formation), embolism (obstruction of a blood vessel by a foreign material), or hypoperfusion (reduced blood flow). The severity and duration of the ischemia determine the extent of brain damage. Symptoms can range from mild, such as transient ischemic attacks (TIAs or "mini-strokes"), to severe, including paralysis, speech difficulties, loss of consciousness, and even death. Immediate medical attention is required for proper diagnosis and treatment to prevent further damage and potential long-term complications.
Cardiac catheterization is a medical procedure used to diagnose and treat cardiovascular conditions. In this procedure, a thin, flexible tube called a catheter is inserted into a blood vessel in the arm or leg and threaded up to the heart. The catheter can be used to perform various diagnostic tests, such as measuring the pressure inside the heart chambers and assessing the function of the heart valves.
Cardiac catheterization can also be used to treat certain cardiovascular conditions, such as narrowed or blocked arteries. In these cases, a balloon or stent may be inserted through the catheter to open up the blood vessel and improve blood flow. This procedure is known as angioplasty or percutaneous coronary intervention (PCI).
Cardiac catheterization is typically performed in a hospital cardiac catheterization laboratory by a team of healthcare professionals, including cardiologists, radiologists, and nurses. The procedure may be done under local anesthesia with sedation or general anesthesia, depending on the individual patient's needs and preferences.
Overall, cardiac catheterization is a valuable tool in the diagnosis and treatment of various heart conditions, and it can help improve symptoms, reduce complications, and prolong life for many patients.
The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.
Equipment design, in the medical context, refers to the process of creating and developing medical equipment and devices, such as surgical instruments, diagnostic machines, or assistive technologies. This process involves several stages, including:
1. Identifying user needs and requirements
2. Concept development and brainstorming
3. Prototyping and testing
4. Design for manufacturing and assembly
5. Safety and regulatory compliance
6. Verification and validation
7. Training and support
The goal of equipment design is to create safe, effective, and efficient medical devices that meet the needs of healthcare providers and patients while complying with relevant regulations and standards. The design process typically involves a multidisciplinary team of engineers, clinicians, designers, and researchers who work together to develop innovative solutions that improve patient care and outcomes.
Hospitalization is the process of admitting a patient to a hospital for the purpose of receiving medical treatment, surgery, or other health care services. It involves staying in the hospital as an inpatient, typically under the care of doctors, nurses, and other healthcare professionals. The length of stay can vary depending on the individual's medical condition and the type of treatment required. Hospitalization may be necessary for a variety of reasons, such as to receive intensive care, to undergo diagnostic tests or procedures, to recover from surgery, or to manage chronic illnesses or injuries.
The Bundle of His is a bundle of specialized cardiac muscle fibers that conduct electrical impulses to the Purkinje fibers, which then stimulate contraction of the ventricles in the heart. It is named after Wilhelm His, Jr., who first described it in 1893.
The Bundle of His is a part of the electrical conduction system of the heart that helps coordinate the contraction of the atria and ventricles to ensure efficient pumping of blood. The bundle originates from the atrioventricular node, which receives electrical impulses from the sinoatrial node (the heart's natural pacemaker) and transmits them through the Bundle of His to the Purkinje fibers.
The Bundle of His is divided into two main branches, known as the right and left bundle branches, which further divide into smaller fascicles that spread throughout the ventricular myocardium. This ensures a coordinated contraction of the ventricles, allowing for efficient pumping of blood to the rest of the body.
Computer-assisted surgery (CAS) refers to the use of computer systems and technologies to assist and enhance surgical procedures. These systems can include a variety of tools such as imaging software, robotic systems, and navigation devices that help surgeons plan, guide, and perform surgeries with greater precision and accuracy.
In CAS, preoperative images such as CT scans or MRI images are used to create a three-dimensional model of the surgical site. This model can be used to plan the surgery, identify potential challenges, and determine the optimal approach. During the surgery, the surgeon can use the computer system to navigate and guide instruments with real-time feedback, allowing for more precise movements and reduced risk of complications.
Robotic systems can also be used in CAS to perform minimally invasive procedures with smaller incisions and faster recovery times. The surgeon controls the robotic arms from a console, allowing for greater range of motion and accuracy than traditional hand-held instruments.
Overall, computer-assisted surgery provides a number of benefits over traditional surgical techniques, including improved precision, reduced risk of complications, and faster recovery times for patients.
Cardiac electrophysiology is a branch of medicine that deals with the study and understanding of the electrical activities of the heart. It involves the diagnosis and treatment of various heart rhythm disorders (arrhythmias) such as bradycardia (slow heart rate), tachycardia (fast heart rate), atrial fibrillation, atrial flutter, ventricular fibrillation, and other rhythm abnormalities.
Cardiac electrophysiologists use various diagnostic tests, including electrocardiograms (ECGs), Holter monitors, event monitors, and invasive procedures such as electrophysiology studies (EPS) and catheter ablation to evaluate and treat heart rhythm disorders. The goal of treatment is to restore a normal heart rhythm and prevent complications associated with arrhythmias, such as stroke or heart failure.
A registry in the context of medicine is a collection or database of standardized information about individuals who share a certain condition or attribute, such as a disease, treatment, exposure, or demographic group. These registries are used for various purposes, including:
* Monitoring and tracking the natural history of diseases and conditions
* Evaluating the safety and effectiveness of medical treatments and interventions
* Conducting research and generating hypotheses for further study
* Providing information to patients, clinicians, and researchers
* Informing public health policy and decision-making
Registries can be established for a wide range of purposes, including disease-specific registries (such as cancer or diabetes registries), procedure-specific registries (such as joint replacement or cardiac surgery registries), and population-based registries (such as birth defects or cancer registries). Data collected in registries may include demographic information, clinical data, laboratory results, treatment details, and outcomes.
Registries can be maintained by a variety of organizations, including hospitals, clinics, academic medical centers, professional societies, government agencies, and industry. Participation in registries is often voluntary, although some registries may require informed consent from participants. Data collected in registries are typically de-identified to protect the privacy of individuals.
Cardiology is a branch of medicine that deals with the diagnosis and treatment of diseases and disorders of the heart and blood vessels. It encompasses the study of the normal functioning of the heart, the investigation and diagnosis of heart disease, and the treatment of various cardiovascular conditions through both surgical and non-surgical interventions. Cardiologists are medical professionals who specialize in this field, providing comprehensive care for patients with conditions such as coronary artery disease, congenital heart defects, valvular heart disease, electrophysiology disorders, and hypertension, among others. They work closely with other healthcare providers to manage cardiovascular risk factors, optimize overall cardiovascular health, and improve patients' quality of life.
In medical terms, the heart is a muscular organ located in the thoracic cavity that functions as a pump to circulate blood throughout the body. It's responsible for delivering oxygen and nutrients to the tissues and removing carbon dioxide and other wastes. The human heart is divided into four chambers: two atria on the top and two ventricles on the bottom. The right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, while the left side receives oxygenated blood from the lungs and pumps it out to the rest of the body. The heart's rhythmic contractions and relaxations are regulated by a complex electrical conduction system.
Thyrotoxicosis is a medical condition that results from an excess of thyroid hormones in the body, leading to an overactive metabolic state. It can be caused by various factors such as Graves' disease, toxic adenoma, Plummer's disease, or excessive intake of thyroid hormone medication. Symptoms may include rapid heart rate, weight loss, heat intolerance, tremors, and increased sweating, among others. Thyrotoxicosis is not a diagnosis itself but a manifestation of various underlying thyroid disorders. Proper diagnosis and management are crucial to prevent complications and improve quality of life.
A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.
Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.
The Autonomic Nervous System (ANS) is a part of the peripheral nervous system that operates largely below the level of consciousness and controls visceral functions. It is divided into two main subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.
The Sympathetic Nervous System (SNS) prepares the body for stressful or emergency situations, often referred to as the "fight or flight" response. It increases heart rate, blood pressure, respiratory rate, and metabolic rate, while also decreasing digestive activity. This response helps the body respond quickly to perceived threats.
The Parasympathetic Nervous System (PNS), on the other hand, promotes the "rest and digest" state, allowing the body to conserve energy and restore itself after the stress response has subsided. It decreases heart rate, blood pressure, and respiratory rate, while increasing digestive activity and promoting relaxation.
These two systems work together to maintain balance in the body by adjusting various functions based on internal and external demands. Disorders of the Autonomic Nervous System can lead to a variety of symptoms, such as orthostatic hypotension, gastroparesis, and cardiac arrhythmias, among others.
Thiophenes are organic compounds that contain a heterocyclic ring made up of four carbon atoms and one sulfur atom. The structure of thiophene is similar to benzene, with the benzene ring being replaced by a thiophene ring. Thiophenes are aromatic compounds, which means they have a stable, planar ring structure and delocalized electrons.
Thiophenes can be found in various natural sources such as coal tar, crude oil, and some foods like onions and garlic. They also occur in certain medications, dyes, and pesticides. Some thiophene derivatives have been synthesized and studied for their potential therapeutic uses, including anti-inflammatory, antiviral, and antitumor activities.
In the medical field, thiophenes are used in some pharmaceuticals as building blocks to create drugs with various therapeutic effects. For example, tipepidine, a cough suppressant, contains a thiophene ring. Additionally, some anesthetics and antipsychotic medications also contain thiophene moieties.
It is important to note that while thiophenes themselves are not typically considered medical terms, they play a role in the chemistry of various pharmaceuticals and other medical-related compounds.
A defibrillator is a medical device that delivers a therapeutic dose of electrical energy to the heart. The aim of the treatment is to restore the normal rhythm of the heart in cases where it has started to beat irregularly, or in a chaotic and unsynchronized manner, which can be life-threatening.
There are two main types of defibrillators: external and implantable. External defibrillators are typically used in emergency situations and are often found in public places such as airports, casinos, and sports arenas. These devices have pads that are placed on the chest of the patient, and they deliver an electrical shock to the heart through the chest wall.
Implantable cardioverter-defibrillators (ICDs) are small devices that are implanted in the chest of patients who are at risk of sudden cardiac death due to life-threatening arrhythmias. ICDs constantly monitor the heart's rhythm and deliver an electrical shock if they detect a dangerous arrhythmia, such as ventricular fibrillation or ventricular tachycardia.
Defibrillators are important medical devices that can save lives in emergency situations. They are often used in conjunction with other treatments, such as medications and cardiac procedures, to manage heart conditions and prevent sudden cardiac death.
The Luria-Nebraska Neuropsychological Battery (LNNB) is a comprehensive neuropsychological assessment tool designed to evaluate various aspects of cognitive functioning. It was developed by the collaboration of Russian neuropsychologist Aleksandr Luria and American psychologists Ralph M. Reitan and Kolja A. Klove.
The LNNB consists of 269 items, grouped into 14 clinical scales and 3 supplementary scales:
1. Motor functions
2. Rhythm
3. Tactile functions
4. Visual functions
5. Receptive speech
6. Expressive speech
7. Writing
8. Reading
9. Arithmetic
10. Memory
11. Intellectual processes
12. Pathognomic signs (items indicative of specific brain damage)
13. Right hemisphere
14. Left hemisphere
15. Mental status
16. Optional items
Each item is scored on a 0, 1, or 2 point scale, with higher scores indicating greater impairment. The clinical scales are designed to assess specific cognitive abilities and functions, while the pathognomic signs help identify the presence of brain damage and lateralization (left or right hemisphere).
The LNNB is administered through a structured interview format and takes approximately 2-3 hours to complete. It provides valuable information about an individual's neuropsychological profile, which can be used for diagnostic purposes, treatment planning, and rehabilitation. However, it requires extensive training and expertise to interpret the results accurately.
It is important to note that while the LNNB has been widely used in clinical settings, its psychometric properties have been debated, and some researchers question its validity and reliability. Therefore, it should be used as part of a comprehensive neuropsychological evaluation rather than as a standalone assessment tool.
Intracranial hemorrhage (ICH) is a type of stroke caused by bleeding within the brain or its surrounding tissues. It's a serious medical emergency that requires immediate attention and treatment. The bleeding can occur in various locations:
1. Epidural hematoma: Bleeding between the dura mater (the outermost protective covering of the brain) and the skull. This is often caused by trauma, such as a head injury.
2. Subdural hematoma: Bleeding between the dura mater and the brain's surface, which can also be caused by trauma.
3. Subarachnoid hemorrhage: Bleeding in the subarachnoid space, which is filled with cerebrospinal fluid (CSF) and surrounds the brain. This type of ICH is commonly caused by the rupture of an intracranial aneurysm or arteriovenous malformation.
4. Intraparenchymal hemorrhage: Bleeding within the brain tissue itself, which can be caused by hypertension (high blood pressure), amyloid angiopathy, or trauma.
5. Intraventricular hemorrhage: Bleeding into the brain's ventricular system, which contains CSF and communicates with the subarachnoid space. This type of ICH is often seen in premature infants but can also be caused by head trauma or aneurysm rupture in adults.
Symptoms of intracranial hemorrhage may include sudden severe headache, vomiting, altered consciousness, confusion, seizures, weakness, numbness, or paralysis on one side of the body, vision changes, or difficulty speaking or understanding speech. Rapid diagnosis and treatment are crucial to prevent further brain damage and potential long-term disabilities or death.
Electrophysiological phenomena refer to the electrical properties and activities of biological tissues, cells, or organ systems, particularly in relation to nerve and muscle function. These phenomena can be studied using various techniques such as electrocardiography (ECG), electromyography (EMG), and electroencephalography (EEG).
In the context of cardiology, electrophysiological phenomena are often used to describe the electrical activity of the heart. The ECG is a non-invasive test that measures the electrical activity of the heart as it contracts and relaxes. By analyzing the patterns of electrical activity, doctors can diagnose various heart conditions such as arrhythmias, myocardial infarction, and electrolyte imbalances.
In neurology, electrophysiological phenomena are used to study the electrical activity of the brain. The EEG is a non-invasive test that measures the electrical activity of the brain through sensors placed on the scalp. By analyzing the patterns of electrical activity, doctors can diagnose various neurological conditions such as epilepsy, sleep disorders, and brain injuries.
Overall, electrophysiological phenomena are an important tool in medical diagnostics and research, providing valuable insights into the function of various organ systems.
Sudden cardiac death (SCD) is a sudden, unexpected natural death caused by the cessation of cardiac activity. It is often caused by cardiac arrhythmias, particularly ventricular fibrillation, and is often associated with underlying heart disease, although it can occur in people with no known heart condition. SCD is typically defined as a natural death due to cardiac causes that occurs within one hour of the onset of symptoms, or if the individual was last seen alive in a normal state of health, it can be defined as occurring within 24 hours.
It's important to note that sudden cardiac arrest (SCA) is different from SCD, although they are related. SCA refers to the sudden cessation of cardiac activity, which if not treated immediately can lead to SCD.
Myocardial infarction (MI), also known as a heart attack, is a medical condition characterized by the death of a segment of heart muscle (myocardium) due to the interruption of its blood supply. This interruption is most commonly caused by the blockage of a coronary artery by a blood clot formed on the top of an atherosclerotic plaque, which is a buildup of cholesterol and other substances in the inner lining of the artery.
The lack of oxygen and nutrients supply to the heart muscle tissue results in damage or death of the cardiac cells, causing the affected area to become necrotic. The extent and severity of the MI depend on the size of the affected area, the duration of the occlusion, and the presence of collateral circulation.
Symptoms of a myocardial infarction may include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating. Immediate medical attention is necessary to restore blood flow to the affected area and prevent further damage to the heart muscle. Treatment options for MI include medications, such as thrombolytics, antiplatelet agents, and pain relievers, as well as procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
The vagus nerve, also known as the 10th cranial nerve (CN X), is the longest of the cranial nerves and extends from the brainstem to the abdomen. It has both sensory and motor functions and plays a crucial role in regulating various bodily functions such as heart rate, digestion, respiratory rate, speech, and sweating, among others.
The vagus nerve is responsible for carrying sensory information from the internal organs to the brain, and it also sends motor signals from the brain to the muscles of the throat and voice box, as well as to the heart, lungs, and digestive tract. The vagus nerve helps regulate the body's involuntary responses, such as controlling heart rate and blood pressure, promoting relaxation, and reducing inflammation.
Dysfunction in the vagus nerve can lead to various medical conditions, including gastroparesis, chronic pain, and autonomic nervous system disorders. Vagus nerve stimulation (VNS) is a therapeutic intervention that involves delivering electrical impulses to the vagus nerve to treat conditions such as epilepsy, depression, and migraine headaches.
Mitral valve insufficiency, also known as mitral regurgitation, is a cardiac condition in which the mitral valve located between the left atrium and left ventricle of the heart does not close properly, causing blood to flow backward into the atrium during contraction of the ventricle. This leads to an increased volume load on the left heart chamber and can result in symptoms such as shortness of breath, fatigue, and fluid retention. The condition can be caused by various factors including valve damage due to degenerative changes, infective endocarditis, rheumatic heart disease, or trauma. Treatment options include medication, mitral valve repair, or replacement surgery depending on the severity and underlying cause of the insufficiency.
Heart valve prosthesis implantation is a surgical procedure where an artificial heart valve is inserted to replace a damaged or malfunctioning native heart valve. This can be necessary for patients with valvular heart disease, including stenosis (narrowing) or regurgitation (leaking), who do not respond to medical management and are at risk of heart failure or other complications.
There are two main types of artificial heart valves used in prosthesis implantation: mechanical valves and biological valves. Mechanical valves are made of synthetic materials, such as carbon and metal, and can last a long time but require lifelong anticoagulation therapy to prevent blood clots from forming. Biological valves, on the other hand, are made from animal or human tissue and typically do not require anticoagulation therapy but may have a limited lifespan and may need to be replaced in the future.
The decision to undergo heart valve prosthesis implantation is based on several factors, including the patient's age, overall health, type and severity of valvular disease, and personal preferences. The procedure can be performed through traditional open-heart surgery or minimally invasive techniques, such as robotic-assisted surgery or transcatheter aortic valve replacement (TAVR). Recovery time varies depending on the approach used and individual patient factors.
Anisoles are organic compounds that consist of a phenyl ring (a benzene ring with a hydroxyl group replaced by a hydrogen atom) attached to a methoxy group (-O-CH3). The molecular formula for anisole is C6H5OCH3. Anisoles are aromatic ethers and can be found in various natural sources, including anise plants and some essential oils. They have a wide range of applications, including as solvents, flavoring agents, and intermediates in the synthesis of other chemicals.
An electrode is a medical device that can conduct electrical currents and is used to transmit or receive electrical signals, often in the context of medical procedures or treatments. In a medical setting, electrodes may be used for a variety of purposes, such as:
1. Recording electrical activity in the body: Electrodes can be attached to the skin or inserted into body tissues to measure electrical signals produced by the heart, brain, muscles, or nerves. This information can be used to diagnose medical conditions, monitor the effectiveness of treatments, or guide medical procedures.
2. Stimulating nerve or muscle activity: Electrodes can be used to deliver electrical impulses to nerves or muscles, which can help to restore function or alleviate symptoms in people with certain medical conditions. For example, electrodes may be used to stimulate the nerves that control bladder function in people with spinal cord injuries, or to stimulate muscles in people with muscle weakness or paralysis.
3. Administering treatments: Electrodes can also be used to deliver therapeutic treatments, such as transcranial magnetic stimulation (TMS) for depression or deep brain stimulation (DBS) for movement disorders like Parkinson's disease. In these procedures, electrodes are implanted in specific areas of the brain and connected to a device that generates electrical impulses, which can help to regulate abnormal brain activity and improve symptoms.
Overall, electrodes play an important role in many medical procedures and treatments, allowing healthcare professionals to diagnose and treat a wide range of conditions that affect the body's electrical systems.
Left ventricular function refers to the ability of the left ventricle (the heart's lower-left chamber) to contract and relax, thereby filling with and ejecting blood. The left ventricle is responsible for pumping oxygenated blood to the rest of the body. Its function is evaluated by measuring several parameters, including:
1. Ejection fraction (EF): This is the percentage of blood that is pumped out of the left ventricle with each heartbeat. A normal ejection fraction ranges from 55% to 70%.
2. Stroke volume (SV): The amount of blood pumped by the left ventricle in one contraction. A typical SV is about 70 mL/beat.
3. Cardiac output (CO): The total volume of blood that the left ventricle pumps per minute, calculated as the product of stroke volume and heart rate. Normal CO ranges from 4 to 8 L/minute.
Assessment of left ventricular function is crucial in diagnosing and monitoring various cardiovascular conditions such as heart failure, coronary artery disease, valvular heart diseases, and cardiomyopathies.
Antithrombins are substances that prevent the formation or promote the dissolution of blood clots (thrombi). They include:
1. Anticoagulants: These are medications that reduce the ability of the blood to clot. Examples include heparin, warfarin, and direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and dabigatran.
2. Thrombolytic agents: These are medications that break down existing blood clots. Examples include alteplase, reteplase, and tenecteplase.
3. Fibrinolytics: These are a type of thrombolytic agent that specifically target fibrin, a protein involved in the formation of blood clots.
4. Natural anticoagulants: These are substances produced by the body to regulate blood clotting. Examples include antithrombin III, protein C, and protein S.
Antithrombins are used in the prevention and treatment of various thromboembolic disorders, such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, and myocardial infarction (heart attack). It is important to note that while antithrombins can help prevent or dissolve blood clots, they also increase the risk of bleeding, so their use must be carefully monitored.
Cardiopulmonary resuscitation (CPR) is a lifesaving procedure that is performed when someone's breathing or heartbeat has stopped. It involves a series of steps that are designed to manually pump blood through the body and maintain the flow of oxygen to the brain until advanced medical treatment can be provided.
CPR typically involves a combination of chest compressions and rescue breaths, which are delivered in a specific rhythm and frequency. The goal is to maintain circulation and oxygenation of vital organs, particularly the brain, until advanced life support measures such as defibrillation or medication can be administered.
Chest compressions are used to manually pump blood through the heart and into the rest of the body. This is typically done by placing both hands on the lower half of the chest and pressing down with enough force to compress the chest by about 2 inches. The compressions should be delivered at a rate of at least 100-120 compressions per minute.
Rescue breaths are used to provide oxygen to the lungs and maintain oxygenation of the body's tissues. This is typically done by pinching the nose shut, creating a seal around the person's mouth with your own, and blowing in enough air to make the chest rise. The breath should be delivered over about one second, and this process should be repeated until the person begins to breathe on their own or advanced medical help arrives.
CPR can be performed by trained laypeople as well as healthcare professionals. It is an important skill that can help save lives in emergency situations where a person's breathing or heartbeat has stopped.
An intracranial embolism is a medical condition that occurs when a blood clot or other foreign material (embolus) forms elsewhere in the body and travels to the blood vessels within the brain. This embolus then blocks the flow of blood in the cerebral arteries, leading to potential damage or death of brain tissue. Common sources of intracranial emboli include heart conditions such as atrial fibrillation, valvular heart disease, or following a heart attack; or from large-vessel atherosclerosis in the carotid arteries. Symptoms can vary depending on the location and size of the obstruction, but may include sudden weakness or numbness, confusion, difficulty speaking, vision loss, severe headache, or even loss of consciousness. Immediate medical attention is required to diagnose and treat intracranial embolism, often involving anticoagulation therapy, endovascular procedures, or surgery.
Premedication is the administration of medication before a medical procedure or surgery to prevent or manage pain, reduce anxiety, minimize side effects of anesthesia, or treat existing medical conditions. The goal of premedication is to improve the safety and outcomes of the medical procedure by preparing the patient's body in advance. Common examples of premedication include administering antibiotics before surgery to prevent infection, giving sedatives to help patients relax before a procedure, or providing medication to control acid reflux during surgery.
Heart valves are specialized structures in the heart that ensure unidirectional flow of blood through its chambers during the cardiac cycle. There are four heart valves: the tricuspid valve and the mitral (bicuspid) valve, located between the atria and ventricles, and the pulmonic (pulmonary) valve and aortic valve, located between the ventricles and the major blood vessels leaving the heart.
The heart valves are composed of thin flaps of tissue called leaflets or cusps, which are supported by a fibrous ring. The aortic and pulmonic valves have three cusps each, while the tricuspid and mitral valves have three and two cusps, respectively.
The heart valves open and close in response to pressure differences across them, allowing blood to flow forward into the ventricles during diastole (filling phase) and preventing backflow of blood into the atria during systole (contraction phase). A properly functioning heart valve ensures efficient pumping of blood by the heart and maintains normal blood circulation throughout the body.
Voltage-sensitive dye imaging (VSDI) is not a medical definition itself, but it is a technique used in the field of physiology and neuroscience to measure the electrical activity of cells, particularly excitable cells such as neurons and cardiac myocytes. Here's a brief explanation:
Voltage-sensitive dyes are fluorescent or luminescent molecules that change their optical properties in response to changes in membrane potential. When these dyes bind to the cell membrane, they can report on the electrical activity of the cell by changing their emission intensity, polarization, or lifetime depending on the voltage across the membrane.
VSDI is a technique that uses these voltage-sensitive dyes to measure changes in membrane potential in a population of cells or even in an entire organ. By illuminating the sample with light and measuring the emitted fluorescence or luminescence, researchers can visualize and quantify the electrical activity of cells in real-time.
VSDI has many applications in basic research, including studying the electrical properties of neurons, mapping neural circuits, investigating the mechanisms of excitation-contraction coupling in cardiac myocytes, and developing new drugs that target ion channels. However, it is not a commonly used clinical technique due to its limitations, such as the need for specialized equipment, the potential for phototoxicity, and the difficulty of interpreting signals from complex tissues.
"Endpoint determination" is a medical term that refers to the process of deciding when a clinical trial or study should be stopped or concluded based on the outcomes or results that have been observed. The endpoint of a study is the primary outcome or result that the study is designed to investigate and measure.
In endpoint determination, researchers use pre-specified criteria, such as statistical significance levels or safety concerns, to evaluate whether the study has met its objectives or if there are any significant benefits or risks associated with the intervention being studied. The decision to end a study early can be based on various factors, including the achievement of a predefined level of efficacy, the emergence of unexpected safety issues, or the realization that the study is unlikely to achieve its intended goals.
Endpoint determination is an important aspect of clinical trial design and conduct, as it helps ensure that studies are conducted in an ethical and scientifically rigorous manner, and that their results can be used to inform medical practice and policy.
Electric injuries refer to damage to the body caused by exposure to electrical energy. This can occur when a person comes into contact with an electrical source, such as a power line or outlet, and the electrical current passes through the body. The severity of the injury depends on various factors, including the voltage and amperage of the electrical current, the duration of exposure, and the path the current takes through the body.
Electric injuries can cause a range of symptoms and complications, including burns, cardiac arrest, muscle damage, nerve damage, and fractures or dislocations (if the victim is thrown by the electrical shock). In some cases, electric injuries can be fatal. Treatment typically involves supportive care to stabilize the patient's vital signs, as well as specific interventions to address any complications that may have arisen as a result of the injury. Prevention measures include following safety guidelines when working with electricity and being aware of potential electrical hazards in one's environment.
Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.
The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.
Examples of animal disease models include:
1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.
Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.
Telemetry is the automated measurement and wireless transmission of data from remote or inaccessible sources to receiving stations for monitoring and analysis. In a medical context, telemetry is often used to monitor patients' vital signs such as heart rate, blood pressure, oxygen levels, and other important physiological parameters continuously and remotely. This technology allows healthcare providers to track patients' conditions over time, detect any abnormalities or trends, and make informed decisions about their care, even when they are not physically present with the patient. Telemetry is commonly used in hospitals, clinics, and research settings to monitor patients during procedures, after surgery, or during extended stays in intensive care units.
Hypertension is a medical term used to describe abnormally high blood pressure in the arteries, often defined as consistently having systolic blood pressure (the top number in a blood pressure reading) over 130 mmHg and/or diastolic blood pressure (the bottom number) over 80 mmHg. It is also commonly referred to as high blood pressure.
Hypertension can be classified into two types: primary or essential hypertension, which has no identifiable cause and accounts for about 95% of cases, and secondary hypertension, which is caused by underlying medical conditions such as kidney disease, hormonal disorders, or use of certain medications.
If left untreated, hypertension can lead to serious health complications such as heart attack, stroke, heart failure, and chronic kidney disease. Therefore, it is important for individuals with hypertension to manage their condition through lifestyle modifications (such as healthy diet, regular exercise, stress management) and medication if necessary, under the guidance of a healthcare professional.
Practice guidelines, also known as clinical practice guidelines, are systematically developed statements that aim to assist healthcare professionals and patients in making informed decisions about appropriate health care for specific clinical circumstances. They are based on a thorough evaluation of the available scientific evidence, consensus of expert opinion, and consideration of patient preferences. Practice guidelines can cover a wide range of topics, including diagnosis, management, prevention, and treatment options for various medical conditions. They are intended to improve the quality and consistency of care, reduce unnecessary variations in practice, and promote evidence-based medicine. However, they should not replace clinical judgment or individualized patient care.
Fibrosis is a pathological process characterized by the excessive accumulation and/or altered deposition of extracellular matrix components, particularly collagen, in various tissues and organs. This results in the formation of fibrous scar tissue that can impair organ function and structure. Fibrosis can occur as a result of chronic inflammation, tissue injury, or abnormal repair mechanisms, and it is a common feature of many diseases, including liver cirrhosis, lung fibrosis, heart failure, and kidney disease.
In medical terms, fibrosis is defined as:
"The process of producing scar tissue (consisting of collagen) in response to injury or chronic inflammation in normal connective tissue. This can lead to the thickening and stiffening of affected tissues and organs, impairing their function."
Hemodynamics is the study of how blood flows through the cardiovascular system, including the heart and the vascular network. It examines various factors that affect blood flow, such as blood volume, viscosity, vessel length and diameter, and pressure differences between different parts of the circulatory system. Hemodynamics also considers the impact of various physiological and pathological conditions on these variables, and how they in turn influence the function of vital organs and systems in the body. It is a critical area of study in fields such as cardiology, anesthesiology, and critical care medicine.
Hyperthyroidism is a medical condition characterized by an excessive production and release of thyroid hormones from the thyroid gland, leading to an increased metabolic rate in various body systems. The thyroid gland, located in the front of the neck, produces two main thyroid hormones: triiodothyronine (T3) and thyroxine (T4). These hormones play crucial roles in regulating many bodily functions, including heart rate, digestion, energy levels, and mood.
In hyperthyroidism, the elevated levels of T3 and T4 can cause a wide range of symptoms, such as rapid heartbeat, weight loss, heat intolerance, increased appetite, tremors, anxiety, and sleep disturbances. Some common causes of hyperthyroidism include Graves' disease, toxic adenoma, Plummer's disease (toxic multinodular goiter), and thyroiditis. Proper diagnosis and treatment are essential to manage the symptoms and prevent potential complications associated with this condition.
A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.
Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.
It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.
I'm not sure I understand your question. "Denmark" is a country located in Northern Europe, and it is not a medical term or concept. It is the southernmost of the Nordic countries, and it consists of the Jutland peninsula and several islands in the Baltic Sea. The capital city of Denmark is Copenhagen.
If you are looking for information about a medical condition that may be associated with Denmark, could you please provide more context or clarify your question? I would be happy to help you with more specific information if I can.
Thoracic surgical procedures refer to the operations that are performed on the thorax, which is the part of the body that lies between the neck and the abdomen and includes the chest cage, lungs, heart, great blood vessels, esophagus, diaphragm, and other organs in the chest cavity. These surgical procedures can be either open or minimally invasive (using small incisions and specialized instruments) and are performed to diagnose, treat, or manage various medical conditions affecting the thoracic organs, such as:
1. Lung cancer: Thoracic surgeons perform lung resections (lobectomy, segmentectomy, wedge resection) to remove cancerous lung tissue. They may also perform mediastinal lymph node dissection to assess the spread of the disease.
2. Esophageal surgery: Surgeries like esophagectomy are performed to treat esophageal cancer or other conditions affecting the esophagus, such as severe GERD (gastroesophageal reflux disease).
3. Chest wall surgery: This includes procedures to repair or replace damaged ribs, sternum, or chest wall muscles and treat conditions like pectus excavatum or tumors in the chest wall.
4. Heart surgery: Thoracic surgeons collaborate with cardiac surgeons to perform surgeries on the heart, such as coronary artery bypass grafting (CABG), valve repair/replacement, and procedures for treating aneurysms or dissections of the aorta.
5. Diaphragm surgery: Procedures like diaphragm plication are performed to treat paralysis or weakness of the diaphragm that can lead to respiratory insufficiency.
6. Mediastinal surgery: This involves operating on the mediastinum, the area between the lungs, to remove tumors, cysts, or other abnormal growths.
7. Pleural surgery: Procedures like pleurodesis or decortication are performed to manage conditions affecting the pleura (the membrane surrounding the lungs), such as pleural effusions, pneumothorax, or empyema.
8. Lung surgery: Thoracic surgeons perform procedures on the lungs, including lobectomy, segmentectomy, or pneumonectomy to treat lung cancer, benign tumors, or other lung diseases.
9. Tracheal surgery: This includes procedures to repair or reconstruct damaged trachea or remove tumors and growths in the airway.
10. Esophageal surgery: Collaborating with general surgeons, thoracic surgeons perform esophagectomy and other procedures to treat esophageal cancer, benign tumors, or other conditions affecting the esophagus.
A Transient Ischemic Attack (TIA), also known as a "mini-stroke," is a temporary period of symptoms similar to those you'd get if you were having a stroke. A TIA doesn't cause permanent damage and is often caused by a temporary decrease in blood supply to part of your brain, which may last as little as five minutes.
Like an ischemic stroke, a TIA occurs when a clot or debris blocks blood flow to part of your nervous system. However, unlike a stroke, a TIA doesn't leave lasting damage because the blockage is temporary.
Symptoms of a TIA can include sudden onset of weakness, numbness or paralysis in your face, arm or leg, typically on one side of your body. You could also experience slurred or garbled speech, or difficulty understanding others. Other symptoms can include blindness in one or both eyes, dizziness, or a severe headache with no known cause.
Even though TIAs usually last only a few minutes, they are a serious condition and should not be ignored. If you suspect you or someone else is experiencing a TIA, seek immediate medical attention. TIAs can be a warning sign that a full-blown stroke is imminent.
A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.
In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:
1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.
It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.
Vagus nerve stimulation (VNS) is a medical treatment that involves the use of a device to send electrical signals to the vagus nerve, which is a key part of the body's autonomic nervous system. The autonomic nervous system controls various automatic functions of the body, such as heart rate and digestion.
In VNS, a small generator is implanted in the chest, and thin wires are routed under the skin to the vagus nerve in the neck. The generator is programmed to send electrical signals to the vagus nerve at regular intervals. These signals can help regulate certain body functions and have been found to be effective in treating a number of conditions, including epilepsy and depression.
The exact mechanism by which VNS works is not fully understood, but it is thought to affect the release of neurotransmitters, chemicals that transmit signals in the brain. This can help reduce seizure activity in people with epilepsy and improve mood and other symptoms in people with depression.
VNS is typically used as a last resort for people who have not responded to other treatments. It is generally considered safe, but like any medical procedure, it does carry some risks, such as infection, bleeding, and damage to the vagus nerve or surrounding tissues.
Cardiovascular agents are a class of medications that are used to treat various conditions related to the cardiovascular system, which includes the heart and blood vessels. These agents can be further divided into several subcategories based on their specific mechanisms of action and therapeutic effects. Here are some examples:
1. Antiarrhythmics: These drugs are used to treat abnormal heart rhythms or arrhythmias. They work by stabilizing the electrical activity of the heart and preventing irregular impulses from spreading through the heart muscle.
2. Antihypertensives: These medications are used to lower high blood pressure, also known as hypertension. There are several classes of antihypertensive drugs, including diuretics, beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors.
3. Anticoagulants: These drugs are used to prevent blood clots from forming or growing larger. They work by interfering with the coagulation cascade, which is a series of chemical reactions that lead to the formation of a blood clot.
4. Antiplatelet agents: These medications are used to prevent platelets in the blood from sticking together and forming clots. They work by inhibiting the aggregation of platelets, which are small cells in the blood that help form clots.
5. Lipid-lowering agents: These drugs are used to lower cholesterol and other fats in the blood. They work by reducing the production or absorption of cholesterol in the body or increasing the removal of cholesterol from the bloodstream. Examples include statins, bile acid sequestrants, and PCSK9 inhibitors.
6. Vasodilators: These medications are used to widen blood vessels and improve blood flow. They work by relaxing the smooth muscle in the walls of blood vessels, causing them to dilate or widen. Examples include nitrates, calcium channel blockers, and ACE inhibitors.
7. Inotropes: These drugs are used to increase the force of heart contractions. They work by increasing the sensitivity of heart muscle cells to calcium ions, which are necessary for muscle contraction.
These are just a few examples of cardiovascular medications that are used to treat various conditions related to the heart and blood vessels. It is important to note that these medications can have side effects and should be taken under the guidance of a healthcare provider.
1. Intracranial Embolism: This is a medical condition that occurs when a blood clot or other particle (embolus) formed elsewhere in the body, travels through the bloodstream and lodges itself in the intracranial blood vessels, blocking the flow of blood to a part of the brain. This can lead to various neurological symptoms such as weakness, numbness, speech difficulties, or even loss of consciousness, depending on the severity and location of the blockage.
2. Intracranial Thrombosis: This is a medical condition that occurs when a blood clot (thrombus) forms within the intracranial blood vessels. The clot can partially or completely obstruct the flow of blood, leading to various symptoms such as headache, confusion, seizures, or neurological deficits, depending on the severity and location of the thrombosis. Intracranial thrombosis can occur due to various factors including atherosclerosis, hypertension, diabetes, and other medical conditions that increase the risk of blood clot formation.
The myocardium is the middle layer of the heart wall, composed of specialized cardiac muscle cells that are responsible for pumping blood throughout the body. It forms the thickest part of the heart wall and is divided into two sections: the left ventricle, which pumps oxygenated blood to the rest of the body, and the right ventricle, which pumps deoxygenated blood to the lungs.
The myocardium contains several types of cells, including cardiac muscle fibers, connective tissue, nerves, and blood vessels. The muscle fibers are arranged in a highly organized pattern that allows them to contract in a coordinated manner, generating the force necessary to pump blood through the heart and circulatory system.
Damage to the myocardium can occur due to various factors such as ischemia (reduced blood flow), infection, inflammation, or genetic disorders. This damage can lead to several cardiac conditions, including heart failure, arrhythmias, and cardiomyopathy.
I'm sorry for any confusion, but "goats" is not a term commonly used in medical definitions. It is a common noun referring to the domesticated animal species Capra aegagrus hircus. If you have any questions about a specific medical condition or term, please provide that and I would be happy to help.
Atrial fibrillation
Atrial Fibrillation Association
Familial atrial fibrillation
Management of atrial fibrillation
European Heart Rhythm Association score of atrial fibrillation
AZD1305
Sports cardiology
Glossary of medicine
HAS-BLED
List of OMIM disorder codes
Pump thrombosis
Rose Medical Center
Left atrial enlargement
Heart Rhythm Society
List of basketball players who died during their careers
Digoxin
Cardiac transient outward potassium current
Reflex syncope
James Mackenzie (cardiologist)
List of plants used in herbalism
Holiday heart syndrome
Digitalis
Betrixaban
Big Bully Busick
Pilsicainide
Doping in American football
Leducq Foundation
Randall Wolf
Ectopic pacemaker
Hypertension
Fibrillation
Atrial fibrillation - Wikipedia
Atrial Fibrillation | cdc.gov
Atrial Fibrillation | AFib | MedlinePlus
Can anxiety cause atrial fibrillation?
Rapid Review Quiz: Atrial Fibrillation
Recent Research on Atrial Fibrillation (AFib)
Atrial Fibrillation (AFib) Awareness Month
Atrial Fibrillation
Medications You Should Avoid With Atrial Fibrillation
Atrial fibrillation: What are the different types?
Postoperative Atrial Fibrillation | ACP Online
Atrial Fibrillation
Atrial fibrillation research - The University of Auckland
Gersak develops Convergent Procedure for atrial fibrillation
Use of intracardiac echocardiography during atrial fibrillation ablation
Atrial fibrillation - Symptoms and causes - Mayo Clinic
Novel molecular targets for atrial fibrillation therapy | Nature Reviews Drug Discovery
Atrial Fibrillation | American Heart Association
Talk:Atrial fibrillation - Citizendium
Indications for Anticoagulation in Atrial Fibrillation | AAFP
Apixaban versus warfarin in patients with atrial fibrillation
VOLTA MEDICAL's VX1 AI software for use in atrial fibrillation mapping now FDA cleared
Long working hours increases the risk of developing atrial fibrillation | ScienceDaily
Smartwatch Effective in Detecting Atrial Fibrillation | UC San Francisco
Atrial Fibrillation
Atrial Fibrillation Archives - PCNA
Does Atrial Fibrillation Increase Stroke Risk?
Atrial Fibrillation - WellSpan Health
Atrial Fibrillation | UT Medical Center
AFib25
- Atrial fibrillation (AF, AFib or A-fib) is an abnormal heart rhythm (arrhythmia) characterized by rapid and irregular beating of the atrial chambers of the heart. (wikipedia.org)
- Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. (cdc.gov)
- What is atrial fibrillation (AFib)? (medlineplus.gov)
- Atrial fibrillation, also known as AFib or AF, is one of the most common types of arrhythmias . (medlineplus.gov)
- What causes atrial fibrillation (AFib)? (medlineplus.gov)
- Who is more likely to develop atrial fibrillation (AFib)? (medlineplus.gov)
- What are the symptoms of atrial fibrillation (AFib)? (medlineplus.gov)
- How is atrial fibrillation (AFib) diagnosed? (medlineplus.gov)
- What are the treatments for atrial fibrillation (AFib)? (medlineplus.gov)
- We've known about atrial fibrillation (AFib) in people for over 100 years. (webmd.com)
- Some people have repeat bouts of atrial fibrillation that come and go on their own, called paroxysmal AFib . (webmd.com)
- September marks National Atrial Fibrillation ( AFib ) Awareness Month, a critically important time for the Heart Rhythm Society to raise awareness for this life-threatening arrhythmia. (abc15.com)
- Atrial fibrillation (AFib) is a common form of abnormal heart rhythm ( heart arrhythmia ) that involves an irregular and often rapid heartbeat. (nationaljewish.org)
- When you have atrial fibrillation (AFib), the medications your doctor gives you are designed to keep your heart rate under control. (webmd.com)
- Atrial fibrillation (AFib) is an irregular and often very rapid heart rhythm. (mayoclinic.org)
- The treatments for AFib and atrial flutter are similar. (mayoclinic.org)
- Some people with atrial fibrillation (AFib) don't notice any symptoms. (mayoclinic.org)
- Atrial fibrillation, also known as AFib or AF, can lead to blood clots, stroke, heart failure and other heart-related complications. (heart.org)
- VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time manual annotation of 3D anatomical and electrical maps of the human atria during atrial fibrillation (AFib) or atrial tachycardia. (prnewswire.com)
- It might be atrial fibrillation , also known as AFib, a common heart arrhythmia that affects about 3 million Americans. (orlandohealth.com)
- What is Atrial Fibrillation (AFib/AF)? (utmedicalcenter.org)
- More than two million people in the United States suffer from atrial fibrillation (also known as AFib or AF), reports the American Heart Association. (utmedicalcenter.org)
- Atrial fibrillation (AF or afib) is a type of heart rhythm disorder, or arrhythmia . (everydayhealth.com)
- This report analyzes emerging trends in the atrial fibrillation (AFib) landscape and profiles key market participants that deliver innovative solutions and maintain leadership in major segments in the care continuum, such as screening and monitoring, image-guided navigation and cardiac mapping, cardiac ablation, and left atrial appendage (LAA) occlusion. (researchandmarkets.com)
- Learn about symptoms of atrial fibrillation, or AFib, and how they may be treated. (cardiosmart.org)
Stroke34
- Atrial fibrillation is associated with an increased risk of heart failure, dementia, and stroke. (wikipedia.org)
- When Should Anticoagulation for Stroke be Initiated in Patients With Atrial Fibrillation? (medscape.com)
- A blood clot leading to a stroke, a heart attack, or heart failure can be the result of prolonged, untreated atrial fibrillation. (uspharmacist.com)
- In addition, before cardioversion or while on antiarrhythmic medications, most patients with atrial fibrillation will receive blood-thinner medications (warfarin, heparin, or aspirin) to prevent blood clots and potential stroke. (uspharmacist.com)
- For those patients who have chronic atrial fibrillation, medications can help control symptoms and prevent complications such as stroke, heart attack, or heart failure. (uspharmacist.com)
- Find out what's happening in your heart during atrial fibrillation and how it can lead to a stroke and other medical problems. (heart.org)
- Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. (nih.gov)
- In this randomized, double-blind trial, we compared apixaban (at a dose of 5 mg twice daily) with warfarin (target international normalized ratio, 2.0 to 3.0) in 18,201 patients with atrial fibrillation and at least one additional risk factor for stroke. (nih.gov)
- In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. (nih.gov)
- Atrial fibrillation is known to contribute to the development of stroke, but also other adverse health outcomes, such as heart failure and stroke-related dementia. (sciencedaily.com)
- Atrial fibrillation increases the risk of stroke by five times. (kkh.com.sg)
- Does Atrial Fibrillation Increase Stroke Risk? (orlandohealth.com)
- Stroke is the fifth-leading cause of death in the United States, and studies show that Americans with atrial fibrillation are five times more likely to suffer a stroke . (orlandohealth.com)
- In the study, which goes by the acronym VIVALDI (Vienna InVestigation of AtriaL fibrillation and thromboembolism in hemoDIalysis patients), the researchers investigated the clinical-scientific conflict regarding the risk of stroke and thromboembolic complications in patients on haemodialysis, especially those with atrial fibrillation. (news-medical.net)
- We found that the prevalence of atrial fibrillation increases with age and is particularly common in male patients,' reports lead author Oliver Königsbrügge, 'but, despite the risk of stroke associated with atrial fibrillation, only half of those affected are being treated with an anticoagulant. (news-medical.net)
- Marcus Säemann, Head of the 6th Medical Department of the Wilhelminen Hospital, says: 'Atrial fibrillation is extremely common in dialysis patients, giving rise to an above-average stroke risk. (news-medical.net)
- He says close follow-up throughout the lives of patients with atrial fibrillation can help prevent risk of stroke. (sciencedaily.com)
- Aug. 22, 2023 A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrial fibrillation and stroke. (sciencedaily.com)
- Nov. 7, 2022 A national study is shedding light on how to more effectively treat atrial fibrillation (AF) -- a common heart rhythm problem associated with increased risk of stroke and heart failure. (sciencedaily.com)
- Your treatment may depend on the cause of your atrial fibrillation, your symptoms, your risk for stroke, and your preferences. (wellspan.org)
- Atrial fibrillation increases the risk of stroke fivefold, and is a major contributor to the development of congestive heart failure as well as more serious, life-threatening arrhythmias. (utmedicalcenter.org)
- In my practice, I've used all the NOAC (novel anticoagulant) therapies available for stroke prevention in my nonvalvular atrial fibrillation patients. (ajmc.com)
- In the AFFIRM study (Atrial Fibrillation Follow-up Investigation of Rhythm Management), an insignificant trend toward increased mortality was noted in the rate control group, and importantly, no evidence suggested that the rhythm-control strategy protected patients from stroke. (medscape.com)
- One concern is that an extensive maze procedure can render the atrial severely hypocontractile, which may elevate the risk of embolic stroke even if AF is substantively suppressed. (medscape.com)
- Atrial Fibrillation: Which Anticoagulant Should I Take to Prevent Stroke? (healthlinkbc.ca)
- Atrial fibrillation increases your risk of stroke. (healthlinkbc.ca)
- Warfarin has been used for many years to reduce the risk of stroke in people with atrial fibrillation. (healthlinkbc.ca)
- The risk of stroke isn't the same for everyone who has atrial fibrillation. (healthlinkbc.ca)
- But on average, people who have atrial fibrillation are 5 times more likely to have a stroke than people who don't have atrial fibrillation. (healthlinkbc.ca)
- Most seriously, it raises the risk of stroke and atrial fibrillation patients are often placed on blood thinners along with other heart medications. (emoryhealthcare.org)
- 1 An increased risk of embolic stroke is a major risk factor associated with the diagnosis of atrial fibrillation. (hcplive.com)
- 2 Although the risk of ischemic stroke related to atrial fibrillation is significantly reduced with warfarin (Coumadin) treatment, anticoagulation treatment can possibly lead to an increased risk of complications from bleeding. (hcplive.com)
- Atrial thrombi may form, causing a significant risk of embolic stroke. (msdmanuals.com)
- That's why it's important to treat the underlying causes of stroke, including heart disease, high blood pressure, atrial fibrillation (fast, irregular heartbeat), high cholesterol, and diabetes. (cdc.gov)
Types of atrial fibrillation3
- What are the types of atrial fibrillation? (medicalnewstoday.com)
- The three main types of atrial fibrillation are: paroxysmal, persistent, and long-term persistent. (medicalnewstoday.com)
- Professor Gersak has been instrumental in developing the Convergent Procedure, a completely closed-chest surgical technique that is designed to treat all types of atrial fibrillation, the most common cardiac arrhythmia (abnormal heartbeat) affecting millions of people worldwide. (news-medical.net)
People with atrial fibrillation3
- Although some people with atrial fibrillation do not notice any symptoms, many patients with this arrhythmia suffer from chest pain, shortness of breath, and palpitations. (uspharmacist.com)
- Although many people with atrial fibrillation are unaware of their arrhythmia until it is discovered during a routine visit to the doctor, most people have occasional or persistent symptoms of palpitations or skipped beats, chest pain, or shortness of breath. (uspharmacist.com)
- Today, however, an increasing number of people with atrial fibrillation can now be treated and cured, thanks to innovative therapies and procedures such as cardiac ablation , available through The Emory Heart & Vascular Center's Atrial Fibrillation Program. (emoryhealthcare.org)
Paroxysmal atrial fibri7
- 2015). Diagnosing paroxysmal atrial fibrillation: Are biomarkers the solution to this elusive arrhythmia? (medicalnewstoday.com)
- Occasional, also called paroxysmal atrial fibrillation. (mayoclinic.org)
- it was with Tsuji's heart: He had paroxysmal atrial fibrillation, an abnormal heart rhythm that would come and go for periods ranging from a few seconds to a few hours. (stanford.edu)
- Stanford Hospital is one of the few California hospitals now offering it for the treatment of paroxysmal atrial fibrillation that does not respond to drug therapy. (stanford.edu)
- Untreated paroxysmal atrial fibrillation can become chronic, resulting in persistent heartbeat irregularities. (stanford.edu)
- Paroxysmal atrial fibrillation (AF) is mostly underpinned by local triggers, particularly from pulmonary veins. (wjgnet.com)
- Background and Objective: Growing evidence shows that certain acute exposures, especially alcohol, may trigger episodes of paroxysmal atrial fibrillation (AF). (lu.se)
Arrhythmia17
- It may also start as other forms of arrhythmia such as atrial flutter that then transform into AF. (wikipedia.org)
- As the most frequent cardiac arrhythmia worldwide, experts estimate that by 2050, 6-12 million people in the United States will experience atrial fibrillation (AF). (medscape.com)
- Both atrial fibrillation and anxiety can lead to irregular heart rhythms, known as arrhythmia. (medicalnewstoday.com)
- Atrial fibrillation (A-fib) is a type of arrhythmia, or irregular heartbeat. (medicalnewstoday.com)
- The treatment for atrial fibrillation depends on the general health of the patient, how often the symptoms occur and their degree of seriousness, and how long the arrhythmia has been present. (uspharmacist.com)
- Atrial fibrillation (AF) is the most common sustained heart rhythm disturbance (arrhythmia). (auckland.ac.nz)
- Atrial fibrillation (AF) is the most common form of cardiac arrhythmia. (nature.com)
- Atrial fibrillation is the most common type of cardiac arrhythmia, and is responsible for substantial morbidity and mortality in the general population. (nature.com)
- Professor Mika Kivimaki, director of the Whitehall II Study, from the Department of Epidemiology at University College London (UK), who led the research, said: "These findings show that long working hours are associated with an increased risk of atrial fibrillation, the most common cardiac arrhythmia. (sciencedaily.com)
- The peer-reviewed study, which used an app specifically designed for the Apple Watch, is believed to be the first on utilizing a smartwatch to detect atrial fibrillation (AF) or any arrhythmia. (ucsf.edu)
- Atrial fibrillation (AF) is an abnormal heart rhythm (arrhythmia) characterised by rapid and irregular beating. (kkh.com.sg)
- Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes. (news-medical.net)
- Atrial fibrillation (say "AY-tree-uhl fih-bruh-LAY-shun") is a common type of irregular heartbeat (arrhythmia). (wellspan.org)
- In some cases, atrial fibrillation may need to be treated with emergency treatment to convert the arrhythmia to normal rhythm. (utmedicalcenter.org)
- Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting approximately 2.2 million Americans1 and responsible for up to 30% of all ischemic strokes.2 It has a higher prevalence among elderly, hypertensive, and diabetic patients and among men, all of whom also have a higher prevalence of coronary artery disease (CAD). (hcplive.com)
- Atrial fibrillation is by far the most common sustained arrhythmia we see and it creates a tremendous amount of symptoms and disability in patients," says Emory Heart & Vascular Center electrophysiologist Angel Leon, MD, Director of Cardiology at Emory University Hospital Midtown. (emoryhealthcare.org)
- Specifically, the investigators are aiming to evaluate if PVI performed with the Arctic Front cryoballoon is superior to AAD as first-line therapy in preventing atrial arrhythmia recurrences (arrhythmia related symptoms, hospitalisations, and health care utilization). (vchri.ca)
Risks of getting atrial fibr1
- But a recent study says that regularly having about 1.2 drinks a day is tied to higher risks of getting atrial fibrillation. (webmd.com)
Suffer from atrial fibrillation3
- More than 2 million Americans suffer from atrial fibrillation, making it the most common of all heart arrhythmias. (uspharmacist.com)
- Between 3 to 5 percent of people over the age of 65 suffer from atrial fibrillation. (utmedicalcenter.org)
- According to the American Heart Association (AHA), about two million Americans suffer from atrial fibrillation. (emoryhealthcare.org)
Symptoms9
- The goal of treatment in patients with atrial fibrillation is to slow the heart down in order to avoid symptoms and prevent complications, and attempt to change the heart rhythm back to a normal rhythm, either through medications or cardioversion (an electric shock to the heart). (uspharmacist.com)
- The diagnosis of atrial fibrillation is made using a variety of tests, including an electrocardiogram (ECG or EKG), an echocardiogram, or a monitor worn throughout the day (and sometimes the night) to record heartbeats and relate them to symptoms. (uspharmacist.com)
- For newly diagnosed atrial fibrillation that is causing distressing symptoms, cardioversion therapy may be the best way to convert the heart back to a normal rhythm. (uspharmacist.com)
- If you have symptoms of atrial fibrillation, make an appointment for a health checkup. (mayoclinic.org)
- Some people feel symptoms when they have episodes of atrial fibrillation. (wellspan.org)
- By maintaining the atrial contribution to cardiac output, symptoms of heart failure and overall quality of life can improve. (medscape.com)
- Atrial fibrillation is considered to be a dangerous health condition, even if it doesn't cause symptoms. (everydayhealth.com)
- Atrial fibrillation causes noticeable symptoms in many people, but some experience no symptoms at all. (everydayhealth.com)
- Although not directly life threatening, atrial fibrillation often produces a fast, irregular, and ineffective heart rhythm that can cause a variety of symptoms. (emoryhealthcare.org)
20231
- Rapid Review Quiz: Atrial Fibrillation - Medscape - Mar 06, 2023. (medscape.com)
Treat atrial fibrillation2
- Your pharmacist can answer your questions about antiarrhythmic medications and bloodthinner drugs used to treat atrial fibrillation. (uspharmacist.com)
- By now being able to treat atrial fibrillation and potentially cure it, we can not only improve the quality of life for many patients, but reduce the number of medications they have to take and reduce trips to the hospital. (emoryhealthcare.org)
Develop atrial fibrillation2
- The study showed that, compared to people who worked a normal week of between 35-40 hours, those who worked 55 hours or more were approximately 40% more likely to develop atrial fibrillation during the following ten years. (sciencedaily.com)
- Patients with Wolff-Parkinson-White syndrome who receive catheter ablation to cure their abnormal heart rhythms are just as likely as non-ablated patients to develop atrial fibrillation no matter what age they receive ablation, according to new study. (sciencedaily.com)
Complications4
- 2019). Complications from Atrial Fibrillation. (cdc.gov)
- Although atrial fibrillation is usually not a life-threatening condition, it should be treated in order to avoid complications. (uspharmacist.com)
- If atrial fibrillation (AF) is left untreated, it can lead to life-threatening complications like strokes or heart failure. (kkh.com.sg)
- Renate Klauser-Braun, Head of the 3rd Medical Department of Danube Hospital, says: 'The available treatments for preventing the complications of atrial fibrillation, especially strokes, in people with healthy kidneys are contraindicated for patients on dialysis or are problematic, because of the complex clinical picture, so that further treatment and antithrombotic prophylaxis must be decided on a case-by-case basis. (news-medical.net)
Patients37
- In patients who do not convert to a normal heart rhythm after cardioversion or in whom this procedure is not appropriate, oral drugs that help slow down the fibrillation and control the heartbeat are the best options. (uspharmacist.com)
- For some patients with a diagnosis of atrial fibrillation, treatment can return their heart to a normal beat pattern. (uspharmacist.com)
- He called for the cardiac surgeons in attendance to encourage cardiologists to refer atrial fibrillation patients for stand-alone, interdisciplinary hybrid procedures that are significantly less invasive, yet allow for a more complete treatment of the condition and improved results. (news-medical.net)
- Factors associated with an increased risk of thromboembolic events in patients with atrial fibrillation (AF) include increasing age, rheumatic heart disease, poor left ventricular function, previous myocardial infarction, hypertension and a past history of a thromboembolic event. (aafp.org)
- A multi-centre study led by MedUni Vienna shows that the prevalence of atrial fibrillation in haemodialysis patients in Vienna is significantly higher than previously thought. (news-medical.net)
- In patients with end-stage kidney disease, who require renal replacement therapy by haemodialysis, the prevalence of atrial fibrillation has hitherto been underestimated. (news-medical.net)
- There is also a lack of scientific clarity as to whether haemodialysis patients with atrial fibrillation benefit from anticoagulation therapy to prevent strokes or whether the benefits are outweighed by the risk of bleeding. (news-medical.net)
- The current study addresses a cross-disciplinary internistic problem and identifies the underestimated role of the concomitant disease atrial fibrillation when it comes to the care of patients with end-stage kidney disease. (news-medical.net)
- Researchers at the Intermountain Medical Center Heart Institute initially set out to discover if catheter ablation reduces the long-term risk of atrial fibrillation and whether the patients' age at the time of the procedure affected their risk. (sciencedaily.com)
- The researchers found that no matter at which age an ablation is performed, adult patients with Wolff-Parkinson-White continue to have a life-long, significant risk of atrial fibrillation. (sciencedaily.com)
- When a lot of physicians encounter patients with Wolff-Parkinson-White and atrial fibrillation, they believe that if the accessory or extra pathway is treated and cured, then the risk of atrial fibrillation is removed," said Intermountain Medical Center Heart Institute cardiologist Jared Bunch, MD, lead researcher of the study. (sciencedaily.com)
- Blood clots commonly form in patients with atrial fibrillation, which makes it one of the most common causes of strokes. (sciencedaily.com)
- Dr. Bunch said it's possible that Wolff-Parkinson-White patients also have an atrial myopathy, or abnormal heart muscle, that leads to long-term atrial fibrillation risk -- independent of the extra pathway. (sciencedaily.com)
- The University of Tennessee Medical Center offers the Mini-Maze Procedure, a minimally invasive surgery that brings hope to atrial fibrillation patients for whom no reasonable cure existed. (utmedicalcenter.org)
- Clinical trials have shown that HMG-CoA reductase inhibitors (statins) are effective for the primary and secondary prevention of CAD.3,4 We hypothesized that statin therapy might have a beneficial effect on the prevention of atrial fibrillation in patients with CAD because of shared risk factors. (hcplive.com)
- We studied patients with stable chronic CAD, without a history of atrial fibrillation, enrolled in an ongoing observational study. (hcplive.com)
- A total of 606 patients with at least 1 year's worth of follow-up data, complete medication information, and information on history of atrial fibrillation were eligible for this study. (hcplive.com)
- Thirty-three patients with previous atrial fi-brillation were excluded, and 124 patients (20%) who had used nonstatin cholesterol-lowering drugs were excluded from the main analysis. (hcplive.com)
- I have used dabigatran in my nonvalvular atrial fibrillation patients. (ajmc.com)
- Patients with nonvalvular atrial fibrillation can certainly be switched from warfarin therapy to a NOAC or a DOAC (direct oral anticoagulant). (ajmc.com)
- High UA levels were shown to increase left atrial size in addition to predisposing patients to new-onset AF. (medpagetoday.com)
- The 2011 Focused Update on the Management of Patients with Atrial Fibrillation-by the American College of Cardiology Foundation (ACCF), the AHA, and the Heart Rhythm Society (HRS)-addressed the issue of strict versus lenient rate control in patients with AF. (ahrq.gov)
- AF's disorganized cardiac electrical impulses and incomplete atrial emptying place patients at significantly increased risk for clots, strokes, and heart failure, the CDC noted. (drbicuspid.com)
- The use of anticoagulation therapy for atrial fibrillation has slowly increased in the last decade, yet many patients at relatively high risk for thromboembolic events are still not receiving anticoagulants. (hcplive.com)
- 3-5 To help guide the clinician in determining the degree of risk of thromboembolic events posed by atrial fibrillation in individual patients, 2 approaches have been employed. (hcplive.com)
- 4,6,7 The other strategy, which is usually applied more selectively, is the use of transthoracic and transesophageal echocardiography to help assess thromboembolic risk in patients with atrial fibrillation. (hcplive.com)
- 8-12 To determine current use of anticoagulation for patients with atrial fibrillation, we recently analyzed the National Ambulatory Medical Care Survey (NAMCS), a large ambulatory patient database, to determine the time trends in the use of anticoagulation therapy for the prevention of thromboembolism in patients with atrial fibrillation. (hcplive.com)
- We examined the 1994 through 2003 NAMCS database to establish the utilization patterns of anticoagulant therapy among patients diagnosed with atrial fibrillation. (hcplive.com)
- Over the course of the study period, approximately 40.5 million atrial fibrillation patient visits occurred, and 18.5 million (45.6%) of these patients received anticoagulant therapy. (hcplive.com)
- 03). Interestingly, the presence of one comorbid factor, diabetes mellitus, which has been shown to be associated with thromboembolism in patients with atrial fibrillation, was associated with a lower frequency of anticoagulation therapy (37% of patients with and 46% of patients without diabetes received anticoagulation therapy). (hcplive.com)
- Atrial fibrillation tends to occur in patients with an underlying heart disorder. (msdmanuals.com)
- Permanent atrial fibrillation cannot be converted to sinus rhythm (the term also includes patients for whom a decision has been made not to attempt conversion to sinus rhythm). (msdmanuals.com)
- Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. (medscape.com)
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. (medscape.com)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (medscape.com)
- Atrial fi brillation required treatment in two patients. (who.int)
- Chez les patients hypertendus, le taux de mortalité était plus élevé uniquement chez les patients admis pour un infarctus du myocarde avec sus-décalage du segment ST. Après ajustement des résultats en fonction des variables de référence, l'hypertension s'est révélé être un facteur prédictif indépendant de l'insuffisance cardiaque (OR = 1,31) et de l'accident vasculaire cérébral (OR = 2,47). (who.int)
American College of1
- Other studies have linked systemic inflammation with the onset and perpetuation of atrial fibrillation ( Journal of the American College of Cardiology , November 20, 2007, Vol. 50:21, pp. 2021-2028). (drbicuspid.com)
Likelihood of developing atrial f1
- Within each of the groups of total cholesterol and each of the groups of change in total cholesterol, relative risks consistently indicated a reduced likelihood of developing atrial fibrillation (table 2). (hcplive.com)
Type of atrial fibrillation2
- Doctors also categorize A-fib as either valvular or nonvalvular.Doctors need to determine the type of atrial fibrillation before they can identify the best treatment. (medicalnewstoday.com)
- In this type of atrial fibrillation, the irregular heart rhythm can't be reset. (mayoclinic.org)
Cases of atrial fibrillation3
- For every 1000 people in the study, an extra 5.2 cases of atrial fibrillation occurred among those working long hours during the ten-year follow-up. (sciencedaily.com)
- During the ten-year follow-up period, there were 1061 new cases of atrial fibrillation. (sciencedaily.com)
- There are more than 300,000 new cases of atrial fibrillation diagnosed each year. (utmedicalcenter.org)
Development of atrial fibrillation2
- We compared the effects of statin use with no cholesterol therapy at all, as well as nonstatin cholesterol-lowering therapy, on the development of atrial fibrillation. (hcplive.com)
- Excess circulating uric acid (UA) that is the hallmark of gout is also associated with effects on left atrial size and the development of atrial fibrillation (AF). (medpagetoday.com)
Catheter ablation1
- As the volume and complexity of catheter ablation of atrial fibrillation (AF) continue to rise, there is increasing attention directed at reducing exposure to ionizing radiation. (nih.gov)
Abnormal5
- Atrial fibrillation is the most common serious abnormal heart rhythm and, as of 2020, affects more than 33 million people worldwide. (wikipedia.org)
- The most common of all abnormal heart rhythms is atrial fibrillation. (uspharmacist.com)
- Atrial fibrillation is caused by abnormal electrical activity in the upper chambers which causes an irregular and rapid rhythm in the lower chambers. (kkh.com.sg)
- Atrial fibrillation is a heart rhythm disorder that involves a rapid heart rate in which the upper heart chambers contract in a disorganized and abnormal manner, disrupting the heart's ability to pump blood. (utmedicalcenter.org)
- Paul Wang is one of the inventors of a treatment for an abnormal heart rhythm, paroxysmal atrial fribrialtion. (stanford.edu)
Persistent2
- 2018). Insights into ablation of persistent atrial fibrillation: Lessons from 6-year clinical outcomes [Abstract]. (medicalnewstoday.com)
- Episodes of atrial fibrillation may come and go, or they may be persistent. (mayoclinic.org)
Irregularly7
- During atrial fibrillation, the heart's upper chambers - called the atria - beat chaotically and irregularly. (mayoclinic.org)
- This makes the ventricles beat irregularly, which leads to an irregular pulse in atrial fibrillation. (utmedicalcenter.org)
- Atrial fibrillation is a problem with the rate or rhythm of the heartbeat that causes the heart to beat quickly or irregularly. (cardiosmart.org)
- Atrial fibrillation is a rapid, irregularly irregular atrial rhythm. (msdmanuals.com)
- In atrial fibrillation, the atria do not contract, and the atrioventricular (AV) conduction system is bombarded with many electrical stimuli, causing inconsistent impulse transmission and an irregularly irregular ventricular rate, which is usually in the tachycardia rate range. (msdmanuals.com)
- When atrial fibrillation is suspected during auscultation of the heart with irregularly irregular beats, obtaining a 12-lead electrocardiography is the next step. (medscape.com)
- Because atrial fibrillation is due to irregular atrial activation at the rate of 350-600 bpm with irregular conduction through the atrioventricular node, it appears on ECG as irregularly irregular narrow complex tachycardia. (medscape.com)
Flutter3
- A-fib and atrial flutter resulted in 193,300 deaths in 2015, up from 29,000 in 1990. (wikipedia.org)
- A person with atrial fibrillation also may have a related heart rhythm problem called atrial flutter. (mayoclinic.org)
- Atrial fibrillation (AF) and atrial flutter (AFL) are cardiac rhythm problems where there is an irregular, rapid heart rate. (vchri.ca)
Diagnosis2
- All subjects were followed until five years after enrollment or occurrence of new-onset atrial fibrillation, as defined by hospital discharge diagnosis or confirmed more than twice in an outpatient setting. (drbicuspid.com)
- The diagnosis of atrial fibrillation is based on the physical finding of an irregular heart rhythm and is confirmed with an ECG or rhythm strip. (medscape.com)
Episodes1
- Atrial fibrillation, or a-fib, as we call it, has made an otherwise athletic man who hikes, plays tennis, and is generally quite active, into a sedentary and fearful person during the episodes. (emofree.com)
Increases3
- The risk of atrial fibrillation increases as you get older, especially when you are over age 65. (medlineplus.gov)
- Nonvalvular atrial fibrillation increases the risk of thromboembolic strokes, ischemic strokes, and other thromboembolic events. (ajmc.com)
- Of note, the risk of atrial fibrillation increases with age, particularly after age 60. (emoryhealthcare.org)
Ablation1
- Tracing Atrial Fibrillation -- 100 Years," "Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation," "Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. (webmd.com)
Cause atrial2
- Can anxiety cause atrial fibrillation? (medicalnewstoday.com)
- Other health problems that can cause atrial fibrillation. (wellspan.org)
Prevention2
- Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. (nature.com)
- Atrial fibrillation affected approximately 2.7 million Americans in 2010, according to the U.S. Centers for Disease Control and Prevention (CDC). (drbicuspid.com)
Apixaban1
- Treatment began with IV unfractionated hepa- history of diabetes mellitus, arterial hypertension, rin (18 UI/kg/h), hydroxychloroquine (200 mg oral- coronary heart disease, peripheral arterial disease, ly 2×/d), and antimicrobial drugs (ceftriaxone 1g by and atrial fibrillation (treated with apixaban [2.5 mg IV infusion/d). (cdc.gov)
Arrhythmias3
- Atrial fibrillation accounts for approximately one-third of hospital admissions due to arrhythmias. (utmedicalcenter.org)
- Atrial fibrillation is one of the most common arrhythmias, affecting between 3 and 6 million adults in the US. (msdmanuals.com)
- Atrial fibrillation (AF) is one of the commonest arrhythmias in clinical practice and has major healthcare and economic implications. (bvsalud.org)
Warfarin1
- This could be a decision for you if you are newly diagnosed with atrial fibrillation or if you are already taking warfarin. (healthlinkbc.ca)
Treatments3
- In recent years, substantial efforts have been invested in developing novel treatments that target the underlying molecular determinants of atrial fibrillation, and several new compounds are under development. (nature.com)
- Different treatments may be used to try to stop atrial fibrillation and keep it from returning. (wellspan.org)
- Until recently, there have been few treatments for atrial fibrillation. (utmedicalcenter.org)
Left atrial ap1
- AF also predisposes a patient to blood clot formation in the atria, particularly the left atrial appendage. (kkh.com.sg)
Evaluate atrial1
- There are several tests that help doctors evaluate atrial fibrillation and determine which type of treatment the patient should receive. (utmedicalcenter.org)
Heart24
- You may be at risk of atrial fibrillation in the early days and weeks after surgery on your heart , lungs, or esophagus. (medlineplus.gov)
- Anxiety may contribute to some heart conditions, including atrial fibrillation. (medicalnewstoday.com)
- Genes and Atrial Fibrillation," "Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. (webmd.com)
- Conditions such as an overactive thyroid gland, untreated high blood pressure or high cholesterol, or heart valve damage can all increase the risk of atrial fibrillation. (uspharmacist.com)
- As such, procedures for treating atrial fibrillation must eliminate invasive chest incisions while allowing surgeons to have direct visualization of the heart and their instruments through endoscopes,' stated Professor Gersak. (news-medical.net)
- Professor Gerhard Wimmer Greinecker, Chief of Cardiac Surgery at the Heart and Vascular Center in Bad Bevensen, Germany, who chaired the atrial fibrillation session, joined Professor Gersak in support of 'subtle surgery' for treating atrial fibrillation. (news-medical.net)
- Techniques such as the Convergent Procedure are the future of atrial fibrillation treatment as it leaves the thoracic cavity and lungs undisturbed, while enabling the cardiac surgeon to have visibility and access to the heart. (news-medical.net)
- Treatment for atrial fibrillation may include medicines, therapy to shock the heart back to a regular rhythm and procedures to block faulty heart signals. (mayoclinic.org)
- People who work long hours have an increased risk of developing an irregular heart rhythm known as atrial fibrillation, according to a study of nearly 85,500 men and women. (sciencedaily.com)
- In AF, electrical impulses in the upper chambers of the heart are chaotic, and the atrial walls quiver rather than contracting normally in moving blood to the lower chambers. (ucsf.edu)
- If not treated, atrial fibrillation can lead to an enlarged heart, scarring and weakening of the upper chamber, and ultimately more serious problems. (orlandohealth.com)
- The study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City also found that Wolff-Parkinson-White syndrome is a long-term cause of atrial fibrillation in addition to traditional risk factors such as obesity, high blood pressure, sedentary lifestyles, and sleep apnea. (sciencedaily.com)
- Atrial fibrillation is a common and irregular and rapid heart rate that occurs when the left ventricle stiffens to counteract high blood pressure while the left atrium dilates in response to higher pressures. (sciencedaily.com)
- In atrial fibrillation, a problem with the heart's electrical system causes the two upper chambers of the heart (called the atria) to quiver, or fibrillate. (wellspan.org)
- Atrial fibrillation can also lead to heart failure. (wellspan.org)
- Atrial fibrillation is caused by health problems that damage or strain the heart and its electrical system . (wellspan.org)
- Conditions that damage or strain the heart are the most common causes of atrial fibrillation. (wellspan.org)
- However, currently available radiofrequency catheters were designed for other heart rhythm problems, not for atrial fibrillation. (stanford.edu)
- While a normal resting heart rate is 60 to 100 beats per minute (bpm), atrial fibrillation can cause your atria to beat 300 to 600 times per minute. (everydayhealth.com)
- With sites at Emory University Hospital, Emory University Hospital Midtown and Emory Saint Joseph's Hospital, Emory's Heart & Vascular Center has one of the few truly comprehensive atrial fibrillation treatment programs of its kind in the Southeast Region. (emoryhealthcare.org)
- Atrial fibrillation is the most common irregular heart rhythm in the United States. (emoryhealthcare.org)
- For many years, atrial fibrillation was thought to be a harmless condition, but it is now known that A- Fib can contribute to additional heart problems over time, including heart failure. (emoryhealthcare.org)
- Atrial fibrillation (AF) and heart failure (HF) are two common heart conditions that are encountered with an increase in death and suffering. (vchri.ca)
- Atrial fibrillation (AF) has strong associations with other cardiovascular diseases, such as heart failure, coronary artery disease (CAD), valvular heart disease, diabetes mellitus, and hypertension. (medscape.com)
Treatment4
- Treatment and control of underlying medical or cardiac problems may help one reduce the risk of developing atrial fibrillation (AF). (kkh.com.sg)
- However, atrial fibrillation is controllable with proper treatment. (utmedicalcenter.org)
- Follow your doctor's recommendations for the treatment of atrial fibrillation and other underlying disorders. (utmedicalcenter.org)
- The purpose of the study is to provide data demonstrating the safety and effectiveness of the PulseSelect™ PFA System for the treatment of atrial fibrillation. (vchri.ca)
Incidence2
- Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. (cdc.gov)
- Corresponding incidence rates of atrial fibrillation per 1,000 person-years were 18 (95% CI, 11-26) for statin users and 37 (95% CI, 26-54) for nonusers (figure). (hcplive.com)
Alcohol2
- Those who worked long hours had a 1.4 times higher risk of developing atrial fibrillation, even after we had adjusted for factors that could affect the risk, such as age, sex, socioeconomic status, obesity, leisure time physical activity, smoking and risky alcohol use," said Prof Kivimaki. (sciencedaily.com)
- In these cases, atrial fibrillation may be related to alcohol or excessive caffeine use, stress, certain drugs, electrolyte or metabolic imbalances, or severe infections. (emoryhealthcare.org)
Heart's1
- Atrial fibrillation is caused by a problem with the heart's electrical system . (wellspan.org)
Prevalence1
- Atrial fibrillation is the most common type of irregular heartbeat, affecting both men and women and showing an increasing prevalence with age. (utmedicalcenter.org)
Anticoagulation therapy2
- So, once atrial fibrillation is confirmed and the CHA 2 DS 2 VASc score is ≥2, I initiate anticoagulation therapy immediately. (ajmc.com)
- Despite clinical criteria guidelines useful for predicting thromboembolic risk, previous studies have shown that anticoagulation therapy is underused in many high-risk populations with atrial fibrillation. (hcplive.com)
Sinus rhythm1
- As AF contributes to pathologic atrial and ventricular remodeling, restoration of sinus rhythm can slow or, in some cases, reverse atrial dilatation and left ventricular dysfunction. (medscape.com)